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Abstract: Typical lipidomics methods incorporate a liquid–liquid extraction with LC–MS 
quantitation; however, the classic sample extraction methods are not high-throughput and do not 
perform well at extracting the full range of lipids especially, the relatively polar species (e.g., acyl-
carnitines and glycosphingolipids). In this manuscript, we present a novel sample extraction 
protocol, which produces a single phase supernatant suitable for high-throughput applications that 
offers greater performance in extracting lipids across the full spectrum of species. We applied this 
lipidomics pipeline to a ruminant fat dose–response study to initially compare and validate the 
different extraction protocols but also to investigate complex lipid biomarkers of ruminant fat intake 
(adjoining onto simple odd chain fatty acid correlations). We have found 100 lipids species with a 
strong correlation with ruminant fat intake. This novel sample extraction along with the LC–MS 
pipeline have shown to be sensitive, robust and hugely informative (>450 lipids species semi-
quantified): with a sample preparation throughput of over 100 tissue samples per day and an 
estimated ~1000 biological fluid samples per day. Thus, this work facilitating both the 
epidemiological involvement of ruminant fat, research into odd chain lipids and also streamlining 
the field of lipidomics (both by sample preparation methods and data presentation). 
Keywords: odd chain lipids; lipid profiling; Folch; protein precipitation; sample preparation; 
relative lipid composition (Mol%) 
 
1. Introduction 
Lipids are generally understood as a class of molecules that have a high solubility in organic 
solvents and typically contain or originate from fatty acids. Although, lipids may be commonly 
derived, research has shown that there is a huge variety both structurally and functionally 
(potentially >40,000 [1]); where they play a vital role in energy production and storage [2,3], 
regulation and signalling [4,5], provide structure and support and membrane formation [6]. Lipids 
are now emerging as biomarkers of dietary/nutritional intakes [7] as well as indicators of 
pathophysiological status [8–11]. As a reaction of lipid-pathophysiological involvements, the field of 
lipidomics has emerged as a discipline that examines and quantifies a large proportion of the lipids 
present in a given sample set. 
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Lipidomics requires an effective isolation protocol that comprehensively extracts lipids from the 
sample as well as an analytical method that allows their identification and quantitation. The typical 
analyte isolation protocols (with/without minor adaptations) that are often used in the literature 
include three different liquid–liquid extractions: Folch and colleagues [12] (cited >65,000 times), Bligh 
and Dyer [13] (cited >52,000 times) or Matyash and colleagues [14] (cited >1000 times). Although these 
extraction protocols are heavily cited and do result in adequate results, there are several caveats with 
their use. Firstly, there is the need to perform duplicate extraction in non-fluid samples to ensure 
optimal recovery of the lipid analytes. This is extremely time consuming, especially for the Folch and 
the Bligh and Dyer methods. Secondly, there are reasonable concerns that using a biphasic extraction 
(producing immiscible aqueous and organic phases) may result in a loss of relatively polar lipids 
(e.g., acyl-carnitines and gangliosides) into the disposed aqueous fractions (consisting of mostly 
methanol and water in these extraction protocols: Folch and the Bligh and Dyer). There are 
publications that use a single phase extraction protocol but they do not appear to solve the problem 
of extracting the relatively more polar lipids since a mixture of methanol, chloroform and tert-butyl 
methyl ether were used [15,16]. 
The technique overwhelmingly used tor analysing the lipidome is mass spectrometry 
hyphenated with chromatography (LC–MS) due to its sensitivity and selectivity; furthermore by 
using a high-resolution accurate mass instrument (e.g., Orbitrap or Time-of-Flight instruments), a 
huge number of analytes can be analysed simultaneously. Reversed phase chromatography is the 
predominant chromatographic technique employed to separate the analytes before entering the mass 
spectrometer to determine their structure and concentration. Variants of a liquid chromatography 
method utilising a C18-column with a water and acetonitrile mix for the weak eluting mobile phase 
and acetonitrile and propan-2-ol for the strong eluting mobile phase are the most commonly used 
[17–22]. These reversed phase C18-column methods both separate lipid based on their lipid class 
assignment (i.e., either phosphatidylcholines or phosphatidyethanolamines head group) and their 
fatty-acyl composition (i.e., chain length and degree of unsaturation) with some degree of isomeric 
separation. 
In this study, we present a lipidomics pipeline that including a novel analyte isolation protocol 
utilising a single phase, which results in a comprehensive lipid extraction suitable for a full range of 
lipid polarities (from polar to non-polar lipids species). This lipidomics method was tested, validated 
and then applied in a rat model investigating ruminant fat biomarkers via a beef tallow dose response 
dietary investigation. 
2. Results 
This lipidomics LC–MS method incorporating both of the described sample preparation 
protocols: protein precipitation (chloroform: methanol: acetone, ~7:3:4) and Folch liquid–liquid 
(chloroform: methanol: water, ~7:3:4), were utilised for the quantitation of lipids in liver samples from 
Sprague–Dawley rats who received one of four experimental diets overfed at 17% above matched 
growth. 
A comparison of the two sample preparation methods on the extraction of the stable isotope-
labelled internal standards are shown in the figure below (see Figure 1). A comparison on the 
samples’ endogenous individual lipid classes are shown in the Supplementary Materials (see 
Supplementary Figure S1 and Table S1). 
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Figure 1. This figure shows the comparison between the two lipid extraction techniques regarding 
their extraction efficiency of the stable isotope internal standards from the rat liver samples (Folch 
liquid–liquid extraction: chloroform: methanol: water, ~7:3:4 , and Protein precipitation liquid 
extraction: chloroform: methanol: acetone, ~7:3:4 ). n = 34 rat liver samples per extraction method. 
The intensity of the internal standards were measured by liquid chromatography with mass 
spectrometry. The significance of the difference between the two extraction protocols are shown by 
the p-value star system; where p ≤ 0.05 was considered statistically significant (*p < 0.05, ** p < 0.01, 
*** p < 0.001). Error bars represent ± standard deviation. Lipid internal standard include: Butyryl-d7-
L-carnitine (abbreviated to IS_Car_4:0-d7), N-tetradecylphosphocholine-d42 (abbreviated to 
IS_LPC_14:0-d42), hexadecanoyl-L-carnitine-d3 (abbreviated to IS_Car_16:0-d3), heptadecanoic-d33 
acid (abbreviated to IS_FA_17:0-d33), 1,2-dimyristoyl-d54-sn-glycero-3-[phospho-L-serine] 
(abbreviated to IS_PS_28:0-d54), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphoinositol (abbreviated 
to IS_PI_34:1-d31), N-palmitoyl-d31-D-erythro-sphingosylphosphorylcholine (abbreviated to 
IS_SM_34:1-d31), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (abbreviated to 
IS_PG_34:1-d31), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphate (abbreviated to IS_PA_34:1-d31), 
N-palmitoyl-d31-D-erythro-sphingosine (abbreviated to IS_Cer_16:0-d31), 1-palmitoyl-d31-2-oleoyl-
sn-glycero-3-phosphocholine (abbreviated to IS_PC_34:1-d31), 1-palmitoyl-d31-2-oleoyl-sn-glycero-
3-phosphoethanolamine (abbreviated to IS_PE_34:1-d31), glyceryl tri(pentadecanoate-d29) 
(abbreviated to IS_TG_45:0-d87). 
As shown the intensity of seven of the internal standards are statistically significantly higher in 
the protein precipitation protocol when compared to the Folch liquid–liquid protocol (between ~30% 
to ~2500% higher), whereas, only two of the internal standards were higher in the Folch liquid–liquid 
protocol (between ~20% and ~37% higher). Additionally, there is far less variation in the protein 
precipitation liquid extraction protocol: 10 out of 13 internal standards had ~2% to ~72% less variation 
in their coefficient of variation (CV). The protein precipitation liquid extraction protocol has also been 
shown to produce a significantly higher detection of the samples’ endogenous lipids, both producing 
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a higher total number of lipid detected (Folch-LLE: 455 lipid species, PPLE: 472 lipid species) and a 
statistically significantly higher total intensity for twelve of the sixteen lipid classes detected (see 
Supplementary Figure S1 and Table S1). Taken as a whole, the protein precipitation protocol 
(chloroform: methanol: acetone, ~7:3:4) showed a greater extraction capability across the full lipid 
hydro-philicity/phobicity range and across the internal standards. Additionally, the high throughput 
of the protein precipitation protocol allows for over 100 tissue samples to be extracted per day 
(including dissection, weighing and tissue extraction ready for LC–MS analysis), whereas, the Folch 
liquid–liquid protocol could take up to three- to four-times longer due to the necessity of duplicate 
extractions and the delicacy of liquid–liquid phase separation. The throughput of the protein 
precipitation protocol (chloroform: methanol: acetone, ~7:3:4) on fluid samples allows an estimated 
~1000 biological fluid sample extractions per day (including aliquoting, sample extraction ready for 
LC–MS analysis) when utilising basic laboratory fluid handling equipment/robots (throughput data 
not shown here). 
The liver lipid concentration (nM/mg) for each experimental diet group of rats are shown in the 
table below (see Table 1), along with the correlation (trendline equation, slope significance, R2 and 
successive change across the groups) of the measured lipid concentration with the percentage 
composition of ruminant fat (beef tallow) in each experimental diet. An R2 threshold of 0.75, slope 
significance p-value < 0.05 and successive increase/decrease were set to establish if there was a strong 
correlation between the lipid concentration and the ruminant fat composition. 
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Table 1. This table shows the liver lipid concentrations from the Sprague–Dawley rats who received one of four experimental diets (n = 8–9 per group). Diet 1: 50% 
corn oil, 16.4% MCT oil and 3.6% beef tallow; Diet 2: 35% corn oil, 28.7% MCT oil and 6.3% beef tallow; Diet 3: 20% corn oil, 41.0% MCT oil and 9.0% beef tallow; 
Diet 4: 5% corn oil, 53.3% MCT oil and 11.7% beef tallow. MCT: medium chain triglyceride oil. Lipid are shown in their shorthand notations with the number of 
carbons and unsaturated bonds in the fatty acid moiety separated by a colon; acyl-carnitines (Carn), ceramides (Cer), cardiolipins (CL), diacylglycerols (DG), 
gangliosides (GM1), hexosylceramides (Hex-Cer), lyso-phosphatidylcholines (LPC), lyso-phosphatidyethanolamines (LPE), lyso-phosphatidylinositols (LPI), lyso-
cardiolipins (Lyso_CL), phosphatidic acids (PA), phosphatidylcholines (PC), phosphatidylethanolamines (PE), phosphatidylglycerol (PG), phosphatidylinositols 
(PI), phosphatidylserines (PS), sulfatides (S), sphingomyelins (SM), triacylglycerides (TG). Lipid concentrations (nM/mg) are shown as mean ± standard deviation 
and were extracted via the protein precipitation liquid extraction protocol (chloroform: methanol: acetone, ~7:3:4). Correlation between the ruminant fat composition 
of the diet and the lipid concentration are depicted by the trendline equation (* denotes statistical significance of the slope: p-value < 0.05) and coefficient of 
determination (R2). Lipid concentrations continually increasing/decreasing across the groups as the ruminant fat composition of the diet increase are emphasised in 
the ‘Successive change across group’ column. Lipids with a significant slope (p-value < 0.05) with an R2 greater than 0.75 and successively increasing/decreasing are 
in bold and highlighted. 
 Diet 1 Diet 2 Diet 3 Diet 4 Trendline Equation R2 
Successive 
Change 
Across 
Groups 
Carn_(C00:0) 99,100 ± 19,200 90,200 ± 38,800 126,000 ± 29,000 92,400 ± 49,600 y = 581x + 97,500 0.02  
Carn_(C02:0) 10,400 ± 4150 10,700 ± 3280 12,900 ± 6740 11,700 ± 5300 y = 226x + 9700 0.49  
Carn_(C03:0) 3430 ± 1380 3590 ± 1820 3760 ± 2170 3830 ± 2240 y = 50.7x + 3260 * 0.97 Increasing 
Carn_(C03:0-2COOH) 713 ± 326 436 ± 299 943 ± 438 700 ± 604 y = 17.3x + 565 0.08  
Carn_(C03:0-OH) ND ± ND 1.46 ± 4.39 2.1 ± 5.94 6.16 ± 13 y = 0.87x − 4.59 0.85  
Carn_(C03:1) 108 ± 64.2 105 ± 58.2 101 ± 75.6 75.5 ± 35.3 y = −3.76x + 126 0.78 Decreasing 
Carn_(C04:0) 1040 ± 847 675 ± 342 1560 ± 659 793 ± 309 y = 5.33x + 976 0.00  
Carn_(C04:0-OH) 952 ± 429 702 ± 503 1730 ± 944 1230 ± 619 y = 69x + 626 0.30  
Carn_(C04:1) 134 ± 56 102 ± 94.4 89.6 ± 63.3 104 ± 78.4 y = −3.79x + 136 0.49  
Carn_(C05:0) 490 ± 534 359 ± 173 857 ± 577 553 ± 437 y = 25.4x + 370 0.18  
Carn_(C05:1) 319 ± 125 255 ± 87.3 317 ± 205 227 ± 99.5 y = −7.93x + 340 0.36  
Carn_(C06:0) 324 ± 287 183 ± 61.5 635 ± 296 234 ± 123 y = 6.74x + 292 0.01  
Carn_(C06:0-2COOH) 511 ± 145 362 ± 124 742 ± 246 477 ± 213 y = 10.3x + 444 0.05  
Carn_(C08:0) 168 ± 174 107 ± 66.6 412 ± 185 186 ± 215 y = 13.3x + 117 0.12  
Carn_(C08:1) 81.7 ± 50.9 102 ± 56.5 124 ± 54.8 88.3 ± 62.7 y = 1.55x + 87.2 0.08  
Carn_(C10:0-2COOH) 353 ± 178 361 ± 124 378 ± 146 296 ± 177 y = −5.7x + 391 0.31  
Carn_(C12:0) 0.265 ± 0.339 0.147 ± 0.353 0.495 ± 0.291 0.412 ± 0.402 y = 0.0292x + 0.106 0.43  
Carn_(C14:0) 11.1 ± 6.52 9.39 ± 8.48 14.8 ± 5.36 13 ± 5.69 y = 0.411x + 8.92 0.38  
Carn_(C15:0) 4.33 ± 2.64 3.76 ± 2.87 4.88 ± 1.52 3.65 ± 0.927 y = −0.0341x + 4.42 0.04  
Carn_(C16:0) 618 ± 339 457 ± 315 739 ± 411 462 ± 226 y = −6.89x + 622 0.03  
Carn_(C16:0-OH) 1.2 ± 1.56 1.52 ± 1.98 1.61 ± 1.35 2.46 ± 2.18 y = 0.143x + 0.601 0.86 Increasing 
Carn_(C16:2) 9.89 ± 7.09 9.69 ± 4.49 7.61 ± 4.01 10.9 ± 4.92 y = 0.0352x + 9.25 0.01  
Carn_(C17:0) 19.2 ± 8.93 13.9 ± 6.7 22.3 ± 9.04 18.4 ± 7.41 y = 0.222x + 16.8 0.05  
Metabolites 2020, 10, 296 6 of 27 
 
Carn_(C18:0) 627 ± 220 541 ± 170 656 ± 154 620 ± 221 y = 3.48x + 584 0.06  
Carn_(C18:0-OH) 5.47 ± 3.31 6.8 ± 3.5 5.41 ± 4.18 8.14 ± 4.52 y = 0.245x + 4.58 0.44  
Carn_(C18:1) 1530 ± 1090 1230 ± 931 1900 ± 958 1130 ± 449 y = −19.6x + 1600 0.04  
Carn_(C18:2) 824 ± 754 631 ± 525 374 ± 157 505 ± 259 y = −45x + 927 0.67  
Carn_(C18:3) 16.8 ± 16.4 14.7 ± 13.3 11.5 ± 6.38 14.8 ± 5.16 y = −0.341x + 17.1 0.29  
Carn_(C20:0) 43.1 ± 38.9 41.9 ± 28.2 32.5 ± 20.4 45.9 ± 22.9 y = −0.037x + 41.1 0.00  
Carn_(C22:5) 2.6 ± 3.13 2.34 ± 2.81 1.7 ± 1.25 1.66 ± 1.06 y = −0.128x + 3.06 * 0.91 Decreasing 
Cer_(32:1) 5.17 ± 1.26 4.31 ± 0.783 5.34 ± 1.78 5.4 ± 1.75 y = 0.0637x + 4.57 0.19  
Cer_(33:1) 2.29 ± 1.92 1.68 ± 1.26 1.48 ± 0.544 1.27 ± 0.925 y = −0.121x + 2.6 * 0.92 Decreasing 
Cer_(34:0) 0.918 ± 0.57 1.19 ± 1.13 2.53 ± 2.19 1.93 ± 1.51 y = 0.162x + 0.402 0.60  
Cer_(34:1) 1.49 ± 0.581 1.23 ± 0.881 1.79 ± 1.01 2.56 ± 0.989 y = 0.14x + 0.699 0.71  
Cer_(35:0) ND ± ND ND ± ND 0.0674 ± 0.191 ND ± ND    
Cer_(35:1) 1.03 ± 1.06 1.61 ± 1.06 1.63 ± 1.08 2.16 ± 1.45 y = 0.126x + 0.641 * 0.91 Increasing 
Cer_(36:0) 7.26 ± 2.79 9.98 ± 5.3 10.5 ± 4.07 13.1 ± 2.89 y = 0.668x + 5.1 * 0.95 Increasing 
Cer_(36:1) 54.5 ± 26.2 55.4 ± 10.4 59.7 ± 16.3 71.7 ± 24.5 y = 2.07x + 44.5 0.83 Increasing 
Cer_(36:2) 6.59 ± 3.55 5.23 ± 1.18 5.94 ± 2.23 6.81 ± 3.13 y = 0.0507x + 5.75 0.06  
Cer_(37:1) 2.23 ± 0.767 1.9 ± 0.723 2.31 ± 0.772 4.23 ± 1.09 y = 0.237x + 0.851 0.61  
Cer_(37:2) ND ± ND ND ± ND 0.066 ± 0.187 ND ± ND    
Cer_(38:0) 2.14 ± 1.19 3.82 ± 3.78 2.1 ± 0.715 2.9 ± 0.626 y = 0.0207x + 2.58 0.01  
Cer_(38:1) 47.9 ± 18.8 34.1 ± 7.21 39.5 ± 10.3 56 ± 13 y = 1.1x + 36 0.16  
Cer_(38:2) 6.76 ± 3.87 4.76 ± 1.57 4.7 ± 0.967 8.02 ± 1.98 y = 0.138x + 5.01 0.09  
Cer_(39:0) 0.188 ± 0.0814 0.221 ± 0.149 0.243 ± 0.153 0.724 ± 0.454 y = 0.0604x − 0.118 0.68 Increasing 
Cer_(39:1) 10.5 ± 3.44 8.36 ± 1.6 10.6 ± 1.62 20.3 ± 3.17 y = 1.17x + 3.48 0.58  
Cer_(39:2) 0.436 ± 0.447 0.332 ± 0.333 0.416 ± 0.342 1.65 ± 0.755 y = 0.138x − 0.347 0.58  
Cer_(40:0) 3.71 ± 0.85 4.12 ± 0.933 4.74 ± 1.44 6.17 ± 0.98 y = 0.296x + 2.42 * 0.92 Increasing 
Cer_(40:1) 126 ± 37.9 116 ± 18.7 146 ± 51 227 ± 39.1 y = 12.3x + 59.4 0.73  
Cer_(40:2) 65.5 ± 24.7 50.8 ± 8.2 63 ± 13.4 105 ± 12.7 y = 4.84x + 34 0.52  
Cer_(41:0) 2.95 ± 0.547 3.91 ± 1.03 4.94 ± 1.2 7.37 ± 1.36 y = 0.529x + 0.744 * 0.94 Increasing 
Cer_(41:1) 72.1 ± 18.6 89.7 ± 20.4 130 ± 88.3 210 ± 48.4 y = 16.8x - 3.18 * 0.91 Increasing 
Cer_(41:2) 51.4 ± 19.1 49.6 ± 11.4 63.3 ± 6.75 144 ± 22.5 y = 10.8x − 5.52 0.70  
Cer_(42:0) 6.21 ± 2.01 8.11 ± 2.54 11.5 ± 5.17 12.2 ± 3.76 y = 0.791x + 3.45 * 0.95 Increasing 
Cer_(42:1) 310 ± 63.3 444 ± 130 624 ± 539 773 ± 305 y = 58.1x + 93.2 * 1.00 Increasing 
Cer_(42:2) 575 ± 161 599 ± 87.4 721 ± 120 1180 ± 187 y = 71.7x + 220 0.79 Increasing 
Cer_(42:3) 105 ± 40.2 92 ± 19.5 103 ± 26.1 151 ± 16.5 y = 5.52x + 70.5 0.54  
Cer_(43:0) 1.31 ± 0.425 2.05 ± 0.699 2.43 ± 0.806 3.07 ± 0.982 y = 0.21x + 0.611 * 0.99 Increasing 
Cer_(43:1) 131 ± 31.2 218 ± 62.9 253 ± 87.4 396 ± 111 y = 30.7x + 14.3 * 0.94 Increasing 
Cer_(43:2) 42.9 ± 7.62 58.9 ± 11.9 64.2 ± 12.8 115 ± 17.2 y = 8.21x + 7.46 0.84 Increasing 
Cer_(44:1) 16.7 ± 4.31 28.5 ± 8.34 38.9 ± 26.1 43 ± 14.8 y = 3.31x + 6.47 * 0.96 Increasing 
Cer_(44:2) 0.908 ± 0.271 1.19 ± 0.288 1.72 ± 1.08 2.08 ± 0.644 y = 0.15x + 0.328 * 0.99 Increasing 
Cer_(45:1) 0.46 ± 0.215 1.19 ± 0.531 1.32 ± 0.618 1.58 ± 0.746 y = 0.129x + 0.149 0.88 Increasing 
Cer_(45:2) ND ± ND 0.00348 ± 0.0104 0.00503 ± 0.0142 ND ± ND y = 0.000574x − 0.000137 1.00  
Cer_(46:1) 0.0023 ± 0.0069 0.0192 ± 0.0266 0.0409 ± 0.0568 0.0568 ± 0.0824 y = 0.00686x − 0.0227 * 1.00 Increasing 
Cer_(46:2) 0.83 ± 0.187 1.53 ± 0.439 1.57 ± 0.516 1.79 ± 0.679 y = 0.108x + 0.603 0.82 Increasing 
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CL_(66:02) 8.65 ± 6.02 22.3 ± 17.1 32.3 ± 17.1 37.7 ± 31.3 y = 3.6x − 2.29 * 0.97 Increasing 
CL_(66:03) 15.8 ± 10.1 23.6 ± 16.4 24.2 ± 13.2 17.3 ± 8.8 y = 0.189x + 18.8 0.02  
CL_(66:04) 15.5 ± 10.7 21.8 ± 10.4 29.7 ± 16.7 27 ± 15.3 y = 1.57x + 11.5 0.76  
CL_(66:05) 40.5 ± 20 39.1 ± 10.7 18.5 ± 10.3 1 ± 0.911 y = −5.15x + 64.2 * 0.92 Decreasing 
CL_(66:06) 66.1 ± 37 67.9 ± 26.4 65.1 ± 38.1 22.6 ± 13.2 y = −4.94x + 93.2 0.62  
CL_(67:02) 4.6 ± 5.88 15.8 ± 13.3 11.3 ± 6.02 10.1 ± 10 y = 0.444x + 7.05 0.11  
CL_(67:03) 13.4 ± 9.85 22.4 ± 14 14.1 ± 6.36 5.97 ± 4.69 y = −1.13x + 22.6 0.35  
CL_(67:05) 0.848 ± 1.74 1.4 ± 2.57 2.58 ± 2.02 3.16 ± 1.62 y = 0.301x − 0.303 * 0.98 Increasing 
CL_(68:00) 0.484 ± 0.502 0.898 ± 1.1 0.998 ± 1.12 0.519 ± 1.01 y = 0.00759x + 0.667 0.01  
CL_(68:01) 105 ± 91.1 260 ± 222 190 ± 107 142 ± 163 y = 1.52x + 163 0.01  
CL_(68:02) 469 ± 385 1010 ± 799 664 ± 355 434 ± 480 y = −16.7x + 772 0.05  
CL_(68:03) 631 ± 421 1030 ± 670 560 ± 261 237 ± 199 y = −61.2x + 1080 0.43  
CL_(68:04) 367 ± 179 439 ± 197 294 ± 113 184 ± 112 y = −25.7x + 518 0.68  
CL_(69:04) 40.4 ± 31.9 66.9 ± 41.7 56.3 ± 27.3 28.8 ± 18.6 y = −1.68x + 61 0.12  
CL_(69:05) 64.8 ± 37.5 67.7 ± 29.7 51.2 ± 20.4 31.1 ± 15.2 y = −4.36x + 87 0.83  
CL_(69:06) 49.7 ± 32.3 49.7 ± 20.5 29.3 ± 11 25.1 ± 10.8 y = −3.49x + 65.1 0.86  
CL_(69:07) 0.245 ± 0.736 1.06 ± 0.942 1.33 ± 1.17 0.685 ± 0.79 y = 0.0589x + 0.38 0.19  
CL_(70:01) 1.45 ± 1.87 6.38 ± 7.09 4.32 ± 2.94 3.91 ± 5.53 y = 0.197x + 2.51 0.12  
CL_(70:02) 61.2 ± 59.7 102 ± 90.1 54.6 ± 31.2 33.4 ± 40.7 y = −4.84x + 99.9 0.35  
CL_(70:03) 470 ± 379 796 ± 600 559 ± 271 340 ± 303 y = −23.2x + 719 0.18  
CL_(70:04) 1270 ± 814 2010 ± 1300 1510 ± 656 950 ± 761 y = −54.1x + 1850 0.18  
CL_(70:05) 1770 ± 889 2210 ± 1060 1670 ± 641 1200 ± 780 y = −83.3x + 2350 0.49  
CL_(70:06) 1280 ± 629 1570 ± 595 1560 ± 688 1440 ± 897 y = 17.4x + 1330 0.20  
CL_(70:07) 882 ± 480 1110 ± 399 1210 ± 657 971 ± 551 y = 13.6x + 939 0.11  
CL_(70:08) 256 ± 199 245 ± 108 147 ± 56.7 89.7 ± 52.6 y = −22.1x + 354 * 0.93 Decreasing 
CL_(70:09) 25.8 ± 18.3 27.1 ± 13.6 17.7 ± 8.62 14.1 ± 7.15 y = −1.65x + 33.8 0.83  
CL_(71:02) 0.744 ± 1.36 2.59 ± 3 1.41 ± 1.38 0.451 ± 0.714 y = −0.0763x + 1.88 0.08  
CL_(71:03) 7.35 ± 7.45 20.2 ± 18.2 18.2 ± 11 9.9 ± 8.38 y = 0.209x + 12.3 0.01  
CL_(71:04) 19.5 ± 12.7 51.1 ± 39.5 65.7 ± 41.9 43 ± 33 y = 3.15x + 20.7 0.32  
CL_(71:05) 56.9 ± 35 116 ± 76.6 130 ± 56.9 107 ± 69.8 y = 6.09x + 55.9 0.44  
CL_(71:06) 106 ± 65.4 164 ± 78.1 192 ± 74.8 164 ± 88.4 y = 7.48x + 99.3 0.52  
CL_(71:07) 76.3 ± 55.8 104 ± 37.6 120 ± 42.8 101 ± 54.8 y = 3.34x + 74.8 0.41  
CL_(71:08) 23.9 ± 25.3 17.1 ± 6.59 5.98 ± 4.09 0.44 ± 0.928 y = −3.02x + 34.9 * 0.98 Decreasing 
CL_(72:01) 0.251 ± 0.441 1.36 ± 1.4 0.758 ± 0.648 0.825 ± 1.56 y = 0.0415x + 0.481 0.10  
CL_(72:02) 0.874 ± 1.29 10.3 ± 12.3 4.1 ± 2.73 4.24 ± 7.52 y = 0.144x + 3.77 0.02  
CL_(72:03) 22.6 ± 21.7 55.2 ± 54.7 23.4 ± 12.2 17.9 ± 25 y = −1.7x + 42.8 0.12  
CL_(72:04) 246 ± 202 374 ± 291 228 ± 110 237 ± 229 y = −6.41x + 320 0.11  
CL_(72:05) 2310 ± 1300 3190 ± 1750 2650 ± 1080 2000 ± 1500 y = −54.4x + 2950 0.14  
CL_(72:06) 10800 ± 5640 12,200 ± 4950 9770 ± 3660 5820 ± 3810 y = −643x + 14,600 0.67  
CL_(72:07) 28,500 ± 15,500 25,400 ± 6760 17,100 ± 6180 7210 ± 4430 y = −2670x + 40,000 * 0.96 Decreasing 
CL_(72:08) 31,100 ± 17,500 24,200 ± 5090 13,800 ± 4820 4420 ± 2860 y = −3350x + 44,000 * 0.99 Decreasing 
CL_(72:09) 1280 ± 774 1150 ± 378 798 ± 339 456 ± 284 y = −105x + 1720 * 0.97 Decreasing 
CL_(72:10) 66.9 ± 45.2 62.8 ± 21.4 62 ± 40.5 70.8 ± 37.4 y = 0.404x + 62.5 0.12  
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CL_(74:06) 1080 ± 745 930 ± 448 489 ± 203 395 ± 366 y = −92.4x + 1430 * 0.94 Decreasing 
CL_(74:07) 4550 ± 2900 3350 ± 1190 2000 ± 712 1650 ± 1280 y = −372x + 5740 * 0.95 Decreasing 
CL_(74:08) 8200 ± 4930 6210 ± 1800 4510 ± 1460 3490 ± 2360 y = −586x + 10,100 * 0.98 Decreasing 
CL_(74:09) 7180 ± 3960 6480 ± 1830 5090 ± 1530 3460 ± 2210 y = −465x + 9110 * 0.97 Decreasing 
CL_(74:10) 3980 ± 2390 3050 ± 652 1860 ± 595 1030 ± 673 y = −372x + 5320 * 1.00 Decreasing 
CL_(74:11) 1240 ± 707 784 ± 177 454 ± 136 284 ± 181 y = −118x + 1600 * 0.96 Decreasing 
CL_(76:09) 802 ± 495 560 ± 202 416 ± 152 633 ± 566 y = −24.1x + 787 0.27  
CL_(76:10) 1300 ± 724 974 ± 335 723 ± 242 960 ± 768 y = −47.1x + 1350 0.48  
CL_(76:11) 1580 ± 894 1140 ± 399 678 ± 217 710 ± 530 y = −114x + 1900 0.87  
CL_(76:12) 1200 ± 704 925 ± 337 513 ± 163 441 ± 328 y = −99.6x + 1530 * 0.94 Decreasing 
DG_(32:0) 194 ± 108 64.5 ± 72.4 75.8 ± 122 99.9 ± 108 y = −10x + 185 0.35  
DG_(34:0) 84.3 ± 167 48.3 ± 145 ND ± ND ND ± ND y = -13.3x + 132 1.00  
DG_(34:1) 6950 ± 4570 3290 ± 1420 3300 ± 1600 4690 ± 4060 y = −251x + 6480 0.26  
GM1_(34:0) 1.47 ± 1.39 5.46 ± 4.45 4.11 ± 4.43 3.26 ± 2.36 y = 0.149x + 2.44 0.10  
GM1_(34:1) 4.89 ± 3.76 15.3 ± 11.1 10.6 ± 9.26 9.27 ± 6.24 y = 0.313x + 7.62 0.06  
GM1_(34:1-OH) 0.054 ± 0.0451 0.0988 ± 0.0944 0.0491 ± 0.0531 0.0338 ± 0.0588 y = −0.00409x + 0.0902 0.26  
GM1_(36:0) ND ± ND 0.0285 ± 0.0603 ND ± ND ND ± ND    
GM1_(36:1) ND ± ND 0.157 ± 0.356 0.125 ± 0.158 0.152 ± 0.285 y = -0.000926x + 0.153 0.02  
Hex-Cer_(32:0) 0.578 ± 0.44 0.383 ± 0.558 0.199 ± 0.291 0.332 ± 0.324 y = −0.0341x + 0.634 0.57  
Hex-Cer_(32:1) ND ± ND 0.0486 ± 0.104 0.0269 ± 0.076 0.0396 ± 0.112 y = −0.00167x + 0.0534 0.17  
Hex-Cer_(34:0-OH) 0.0882 ± 0.264 0.0548 ± 0.164 0.0611 ± 0.173 ND ± ND y = −0.00502x + 0.0997 0.58  
Hex-Cer_(34:1) 0.565 ± 0.791 1.27 ± 1.2 1.74 ± 1.87 4.68 ± 1.85 y = 0.475x − 1.57 0.84 Increasing 
Hex-Cer_(34:1-OH) 0.295 ± 0.719 ND ± ND 0.0372 ± 0.105 0.208 ± 0.587 y = −0.016x + 0.31 0.25  
Hex-Cer_(34:2) 0.32 ± 0.418 0.318 ± 0.598 ND ± ND 0.424 ± 1.2 y = 0.0138x + 0.255 0.88  
Hex-Cer_(34:2-OH) 0.614 ± 0.37 0.518 ± 0.375 0.39 ± 0.512 0.306 ± 0.488 y = -0.039x + 0.755 * 0.99 Decreasing 
Hex-Cer_(35:0) 0.0425 ± 0.127 ND ± ND 0.663 ± 0.389 1.37 ± 1.56 y = 0.157x − 0.579 0.95  
Hex-Cer_(35:1) 0.551 ± 0.625 0.649 ± 0.567 1.03 ± 0.58 1.66 ± 1.57 y = 0.137x − 0.0781 * 0.91 Increasing 
Hex-Cer_(36:0-OH) 2.03 ± 1.06 2.58 ± 2.01 3.51 ± 1.07 4.75 ± 2.01 y = 0.337x + 0.642 * 0.97 Increasing 
Hex-Cer_(36:1) 0.235 ± 0.413 ND ± ND 0.688 ± 0.661 0.264 ± 0.491 y = 0.0151x + 0.274 0.06  
Hex-Cer_(36:2) ND ± ND 0.0816 ± 0.245 0.289 ± 0.574 0.638 ± 0.942 y = 0.103x − 0.591 0.98  
Hex-Cer_(37:0) ND ± ND 0.0835 ± 0.167 0.0639 ± 0.181 0.151 ± 0.295 y = 0.0125x − 0.013 0.55  
Hex-Cer_(37:0-OH) 9.56 ± 9.47 14.3 ± 11.8 38 ± 31.6 80.1 ± 67.3 y = 8.72x − 31.2 0.89 Increasing 
Hex-Cer_(37:1) 0.0494 ± 0.148 0.167 ± 0.252 0.0497 ± 0.141 ND ± ND y = 0.0000556x + 0.0884 0.00  
Hex-Cer_(37:2) 2.12 ± 2.98 3.57 ± 5.06 0.717 ± 2.03 0.957 ± 2.02 y = −0.235x + 3.64 0.39  
Hex-Cer_(38:0-OH) ND ± ND 3.91 ± 5.51 2.8 ± 4.29 7.46 ± 8.35 y = 0.657x − 1.19 0.53  
Hex-Cer_(38:1) 14.8 ± 16 13.4 ± 12.3 22.6 ± 25.1 32.2 ± 25.2 y = 2.27x + 3.35 0.84  
Hex-Cer_(38:2) 0.569 ± 0.899 2.09 ± 1.23 1.81 ± 1.58 0.813 ± 0.906 y = 0.0167x + 1.19 0.01  
Hex-Cer_(39:0-OH) 5.62 ± 3.39 2.48 ± 3.2 4.86 ± 13.8 19.3 ± 21.8 y = 1.61x − 4.24 0.54  
Hex-Cer_(39:2) 20.7 ± 4.71 21.6 ± 7.5 24.1 ± 7.77 32.5 ± 7.01 y = 1.4x + 14 0.83 Increasing 
Hex-Cer_(40:0) 10.1 ± 12.2 9.47 ± 10 15.5 ± 15 19.7 ± 9.5 y = 1.29x + 3.82 0.87  
Hex-Cer_(40:0-OH) ND ± ND 5 ± 15 ND ± ND ND ± ND    
Hex-Cer_(40:1) 174 ± 204 221 ± 120 275 ± 249 403 ± 206 y = 27.4x + 58.3 * 0.94 Increasing 
Hex-Cer_(40:1-OH) 7.04 ± 2.48 6.38 ± 2.94 7.95 ± 2.57 5.14 ± 1.51 y = −0.153x + 7.8 0.20  
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Hex-Cer_(40:2) 0.266 ± 0.178 0.854 ± 0.804 0.806 ± 1.66 0.672 ± 1.21 y = 0.0433x + 0.318 0.32  
Hex-Cer_(40:2-OH) 2.1 ± 1.32 2.17 ± 0.891 2.76 ± 1.9 1.86 ± 1.91 y = -0.00481x + 2.26 0.00  
Hex-Cer_(41:0-OH) 23.9 ± 8.7 33 ± 10.5 26.8 ± 4.88 20.1 ± 7.48 y = −0.652x + 30.9 0.17  
Hex-Cer_(41:1) 4.01 ± 1.31 5.78 ± 1.62 7.62 ± 3.75 17.7 ± 5.68 y = 1.59x − 3.38 0.82 Increasing 
Hex-Cer_(41:2) 4.6 ± 1.03 4.78 ± 1.62 3.34 ± 1.5 3.71 ± 1.89 y = −0.152x + 5.27 0.59  
Hex-Cer_(42:0) 0.394 ± 0.271 0.329 ± 0.289 0.466 ± 0.227 0.705 ± 0.432 y = 0.0396x + 0.17 0.71  
Hex-Cer_(42:0-OH) 21.8 ± 14.5 21.3 ± 6.34 30.3 ± 20.7 34.6 ± 14.3 y = 1.76x + 13.6 0.88  
Hex-Cer_(42:1) 14.1 ± 4.31 20.5 ± 5.26 22.5 ± 10.5 34.5 ± 12.3 y = 2.34x + 4.99 * 0.92 Increasing 
Hex-Cer_(42:2) 7.61 ± 2.29 11.3 ± 3.91 14.3 ± 7.05 23.1 ± 7.39 y = 1.83x + 0.061 * 0.93 Increasing 
Hex-Cer_(42:2-OH) 4.99 ± 1.66 5.86 ± 2.35 5.19 ± 1.86 7.37 ± 3.43 y = 0.24x + 4.02 0.60  
Hex-Cer_(43:0) 0.0149 ± 0.0296 0.0155 ± 0.0308 0.145 ± 0.175 0.129 ± 0.153 y = 0.0175x − 0.0576 0.74  
Hex-Cer_(43:0-OH) 0.416 ± 0.255 0.583 ± 0.36 0.338 ± 0.18 0.32 ± 0.277 y = −0.0197x + 0.565 0.33  
Hex-Cer_(43:1) 1.69 ± 0.642 3.13 ± 1.14 3.47 ± 1.46 7.28 ± 2.91 y = 0.634x - 0.955 0.86 Increasing 
Hex-Cer_(43:2) 0.866 ± 0.212 0.858 ± 0.321 0.799 ± 0.314 1.24 ± 0.718 y = 0.0394x + 0.64 0.46  
LPC_(14:0) 1.4 ± 0.645 1.58 ± 0.732 2.09 ± 0.96 2.96 ± 1.34 y = 0.192x + 0.537 * 0.92 Increasing 
LPC_(15:0) 6.02 ± 1.49 7.53 ± 2.48 7.69 ± 2.62 8.38 ± 2.62 y = 0.268x + 5.35 0.88 Increasing 
LPC_(16:0) 1430 ± 246 1560 ± 272 1690 ± 300 1900 ± 427 y = 57x + 1210 * 0.98 Increasing 
LPC_(16:1) 8.56 ± 4.67 11.3 ± 6.3 19.6 ± 8.38 33.1 ± 10.5 y = 3.03x - 5.07 * 0.92 Increasing 
LPC_(17:0) 64.5 ± 10.8 72.2 ± 13.1 74.9 ± 11.2 75.6 ± 27.5 y = 1.33x + 61.6 0.84 Increasing 
LPC_(17:1) 0.395 ± 0.314 0.576 ± 0.537 2.2 ± 1.09 6.08 ± 1.62 y = 0.692x − 2.98 0.83 Increasing 
LPC_(18:0) 3720 ± 504 3550 ± 634 3450 ± 619 3300 ± 520 y = −50.4x + 3890 * 0.99 Decreasing 
LPC_(18:1) 252 ± 47.9 247 ± 56.4 332 ± 51.2 549 ± 121 y = 36.1x + 68.5 0.79  
LPC_(18:2) 266 ± 52.6 232 ± 46.8 217 ± 19.7 198 ± 38.2 y = -8.11x + 290 * 0.97 Decreasing 
LPC_(18:3) 80 ± 15.2 88.6 ± 22.2 93 ± 19.4 102 ± 22.5 y = 2.61x + 71 * 0.98 Increasing 
LPC_(18:4) 0.515 ± 0.37 0.758 ± 0.481 1.45 ± 0.744 3.08 ± 1.42 y = 0.311x − 0.926 0.88 Increasing 
LPC_(19:0) 47.8 ± 5.54 37.7 ± 12.1 36.2 ± 8.19 40.1 ± 12.9 y = −0.911x + 47.4 0.38  
LPC_(20:0) 45.5 ± 12 29 ± 9.84 22.8 ± 4.24 18.5 ± 5.39 y = −3.23x + 53.7 * 0.90 Decreasing 
LPC_(20:4) 344 ± 121 289 ± 32.6 288 ± 82.8 282 ± 53.7 y = −6.93x + 354 0.69 Decreasing 
LPC_(20:5) 26.9 ± 9.49 21.5 ± 4.39 20.2 ± 2.89 21 ± 5.62 y = −0.704x + 27.8 0.65  
LPC_(21:0) 1.11 ± 0.227 0.89 ± 0.305 0.75 ± 0.257 0.896 ± 0.324 y = −0.029x + 1.13 0.46  
LPC_(22:4) 5.12 ± 2.83 3.37 ± 0.794 3.21 ± 0.909 3.52 ± 1 y = −0.184x + 5.21 0.52  
LPC_(22:5) 12.3 ± 9.44 6.01 ± 2.43 5.97 ± 2.51 9.46 ± 4.97 y = −0.317x + 10.9 0.13  
LPC_(22:6) 21.1 ± 13 14.4 ± 3.33 15.4 ± 4.74 26.5 ± 5.75 y = 0.637x + 14.5 0.16  
LPE_(16:0) 9.94 ± 2.69 11.4 ± 3.82 16.7 ± 4.93 25.8 ± 11.7 y = 1.96x + 0.977 * 0.91 Increasing 
LPE_(16:1) ND ± ND 0.0351 ± 0.0709 0.0116 ± 0.0329 0.177 ± 0.163 y = 0.0263x − 0.162 0.63  
LPE_(17:0) 0.637 ± 0.392 0.724 ± 0.401 1.1 ± 0.151 1.61 ± 0.982 y = 0.122x + 0.0842 * 0.92 Increasing 
LPE_(18:0) 50.7 ± 12.9 50.3 ± 14.6 57.1 ± 12.6 67.7 ± 29.3 y = 2.14x + 40.1 0.84  
LPE_(18:1) 5.94 ± 1.16 4.7 ± 1.21 6.6 ± 1.36 11 ± 3.41 y = 0.633x + 2.22 0.65  
LPE_(18:2) 5.04 ± 3.8 2.76 ± 1.33 2.93 ± 1.15 2.42 ± 1.28 y = −0.285x + 5.47 0.70  
LPE_(18:3) 1.85 ± 0.528 2.14 ± 0.76 2.96 ± 0.944 4.22 ± 1.93 y = 0.294x + 0.546 * 0.93 Increasing 
LPE_(20:0) 0.444 ± 0.114 0.358 ± 0.169 0.31 ± 0.121 0.247 ± 0.17 y = −0.0237x + 0.521 * 0.99 Decreasing 
LPE_(20:3) 0.472 ± 0.645 0.556 ± 0.49 0.945 ± 0.831 1.49 ± 1.22 y = 0.128x − 0.11 * 0.92 Increasing 
LPE_(20:4) 22.9 ± 12.3 17.9 ± 4.53 20.8 ± 7.66 28.6 ± 11.8 y = 0.741x + 16.9 0.33  
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LPE_(20:5) 1.53 ± 1.12 0.932 ± 0.388 0.827 ± 0.252 0.645 ± 0.248 y = −0.102x + 1.77 0.86 Decreasing 
LPE_(22:4) 0.264 ± 0.791 ND ± ND 0.0209 ± 0.0389 0.35 ± 0.382 y = 0.00267x + 0.19 0.00  
LPI_(16:0) 64.1 ± 21.4 82.6 ± 36.1 113 ± 39.7 103 ± 45 y = 5.45x + 49 0.76  
LPI_(17:0) 5.04 ± 3.17 6.56 ± 3.13 7.63 ± 3.8 5.1 ± 4.85 y = 0.0463x + 5.73 0.02  
LPI_(18:0) 1210 ± 404 1510 ± 647 1510 ± 376 1200 ± 547 y = −1.11x + 1370 0.00  
LPI_(18:1) 46.2 ± 22.3 47.6 ± 17.7 57.4 ± 21.6 59.5 ± 26.8 y = 1.84x + 38.6 * 0.90 Increasing 
LPI_(18:2) 18.9 ± 10.4 17.8 ± 8 16.9 ± 5.86 7.43 ± 4.45 y = −1.31x + 25.3 0.74 Decreasing 
LPI_(20:0) 0.0835 ± 0.1 ND ± ND 0.18 ± 0.264 0.0895 ± 0.127 y = 0.00319x + 0.0918 0.06  
LPI_(20:2) 1.7 ± 1.09 1.18 ± 1.36 1.09 ± 0.93 0.661 ± 1.15 y = −0.119x + 2.07 * 0.94 Decreasing 
LPI_(20:3) 25.8 ± 14.7 47.1 ± 27.2 85.6 ± 35.3 125 ± 49.4 y = 12.4x − 24.4 * 0.98 Increasing 
LPI_(20:4) 288 ± 102 453 ± 238 447 ± 108 360 ± 145 y = 7.78x + 328 0.12  
LPI_(22:4) 4.72 ± 2.12 3.96 ± 2.88 4.26 ± 2.1 3.26 ± 1.91 y = −0.151x + 5.21 0.74  
LPI_(22:5) 1.15 ± 1.67 1.51 ± 1.76 0.418 ± 0.701 1.98 ± 1.41 y = 0.0518x + 0.868 0.08  
LPI_(22:6) 2.06 ± 1.55 2.04 ± 1.58 0.605 ± 0.968 2.65 ± 2.37 y = 0.0124x + 1.74 0.00  
Lyso_CL_(52:01) 0.698 ± 1.02 1.75 ± 1.42 1.51 ± 0.755 1.99 ± 1.82 y = 0.135x + 0.457 0.70  
Lyso_CL_(52:02) 11.4 ± 10.4 13.7 ± 7.67 10.7 ± 4.9 12.5 ± 11.6 y = 0.0111x + 12 0.00  
Lyso_CL_(52:03) 50.5 ± 42.8 32.9 ± 12.7 18.7 ± 8.32 17.2 ± 14.1 y = −4.23x + 62.2 * 0.90 Decreasing 
Lyso_CL_(52:04) 30.3 ± 36.6 19.7 ± 9.87 9.23 ± 4.21 10.4 ± 9.01 y = −2.6x + 37.3 0.86  
Lyso_CL_(52:05) ND ± ND ND ± ND ND ± ND 0.785 ± 1.84    
Lyso_CL_(53:04) ND ± ND 0.154 ± 0.261 0.221 ± 0.404 1.55 ± 1.72 y = 0.259x − 1.69 0.79  
Lyso_CL_(54:02) ND ± ND 0.0851 ± 0.178 0.0412 ± 0.117 0.655 ± 1.15 y = 0.106x − 0.689 0.69  
Lyso_CL_(54:03) 24.8 ± 26.6 13.2 ± 7.1 9.89 ± 3.88 19.5 ± 18.6 y = −0.711x + 22.3 0.14  
Lyso_CL_(54:04) 172 ± 166 94.9 ± 32.4 67.3 ± 25.2 87 ± 72.4 y = −10.5x + 185 0.63  
Lyso_CL_(54:05) 405 ± 411 234 ± 94 144 ± 60.4 133 ± 104 y = −33.6x + 486 0.87 Decreasing 
Lyso_CL_(54:06) 548 ± 555 247 ± 117 122 ± 47.8 65.7 ± 51.8 y = −58.2x + 691 0.89 Decreasing 
Lyso_CL_(56:05) 42.9 ± 55.3 13.1 ± 3.27 4.18 ± 2.41 13.5 ± 16.1 y = −3.6x + 45.9 0.55  
Lyso_CL_(56:06) 135 ± 153 42.7 ± 13.4 20.9 ± 8.33 40.2 ± 42.2 y = −11.3x + 146 0.60  
PA_(30:0) 1.19 ± 2.41 2.63 ± 2.77 6.15 ± 4.83 30 ± 23.7 y = 3.33x − 15.5 0.74 Increasing 
PA_(30:1) 17.2 ± 17.8 17.1 ± 11.8 20.7 ± 9.98 73.9 ± 41.3 y = 6.43x − 17 0.65  
PA_(32:1) 43.2 ± 46.5 56.3 ± 17.7 84.6 ± 30.3 291 ± 143 y = 28.6x − 99.9 0.74 Increasing 
PA_(32:2) 223 ± 216 180 ± 96 154 ± 86.4 166 ± 70.4 y = −7.3x + 237 0.71  
PA_(34:1) 387 ± 401 402 ± 135 538 ± 176 1010 ± 307 y = 74.3x + 16.2 0.79 Increasing 
PA_(34:2) 2330 ± 2170 1990 ± 756 1600 ± 787 1230 ± 358 y = −137x + 2830 * 1.00 Decreasing 
PA_(36:1) 1440 ± 924 1640 ± 435 1410 ± 877 1240 ± 323 y = −30.7x + 1670 0.43  
PA_(36:2) 3310 ± 1750 2480 ± 918 2250 ± 1360 1910 ± 1020 y = −164x + 3740 * 0.92 Decreasing 
PA_(36:4) 10,300 ± 9970 6760 ± 2840 7130 ± 3790 9580 ± 4540 y = −66.3x + 8950 0.02  
PA_(38:3) 1390 ± 910 1150 ± 544 1590 ± 683 2590 ± 1230 y = 150x + 535 0.68  
PA_(38:4) 42,400 ± 40,100 27,100 ± 11,700 25,400 ± 17,000 23,000 ± 7630 y = −2220x + 46,400 0.78 Decreasing 
PA_(38:5) 3280 ± 2800 2230 ± 911 2430 ± 1180 3310 ± 1300 y = 10.7x + 2730 0.00  
PA_(40:5) 1730 ± 1530 838 ± 336 871 ± 449 1110 ± 412 y = −67.7x + 1650 0.33  
PC_(30:0) 6.27 ± 6.94 21.5 ± 23.9 39.3 ± 18.4 81.4 ± 23.1 y = 9.01x − 31.8 * 0.94 Increasing 
PC_(30:1) 8.63 ± 6.24 12.9 ± 8.52 40.6 ± 32.6 188 ± 120 y = 21x − 97.8 0.74 Increasing 
PC_(31:0) 54.7 ± 17.4 78.7 ± 33.5 85.4 ± 22.6 179 ± 44.5 y = 14.1x − 8.1 0.80 Increasing 
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PC_(32:0) 1750 ± 251 1930 ± 493 1650 ± 237 1950 ± 234 y = 11.9x + 1730 0.08  
PC_(32:1) 222 ± 110 352 ± 101 1240 ± 835 4860 ± 1550 y = 548x − 2530 0.77 Increasing 
PC_(32:2) 565 ± 249 496 ± 222 646 ± 223 1350 ± 659 y = 92.8x + 54.5 0.67  
PC_(33:0) 28.2 ± 8.55 39.9 ± 13 49.6 ± 7.5 102 ± 25.7 y = 8.56x − 10.6 0.84 Increasing 
PC_(33:1) 148 ± 45.4 267 ± 71.4 540 ± 136 1700 ± 388 y = 183x − 733 0.80 Increasing 
PC_(33:2) 470 ± 56.2 515 ± 187 574 ± 241 566 ± 180 y = 12.9x + 433 0.85  
PC_(34:0) 789 ± 267 732 ± 165 615 ± 45.6 644 ± 83.3 y = −20.4x + 851 0.79  
PC_(34:1) 4160 ± 763 5580 ± 931 8080 ± 829 15,100 ± 1050 y = 1310x − 1780 0.88 Increasing 
PC_(34:2) 11,900 ± 2050 14,700 ± 1880 15,200 ± 1930 20,400 ± 2030 y = 963x + 8180 0.90 Increasing 
PC_(34:3) 3270 ± 1090 3620 ± 834 5400 ± 998 9050 ± 1860 y = 708x − 82.3 0.87 Increasing 
PC_(35:0) 28.3 ± 9.27 32.3 ± 9.11 38.3 ± 6.8 71.2 ± 15.2 y = 4.99x + 4.36 0.79 Increasing 
PC_(35:1) 108 ± 32 166 ± 36.7 297 ± 52.6 891 ± 153 y = 91.9x − 337 0.79 Increasing 
PC_(35:2) 1240 ± 238 1530 ± 305 1530 ± 433 1640 ± 369 y = 44.4x + 1150 0.82  
PC_(36:0) 76.2 ± 27.6 66.4 ± 16.6 55.2 ± 22.9 83.4 ± 16.5 y = 0.385x + 67.4 0.01  
PC_(36:1) 3060 ± 753 3610 ± 756 5450 ± 944 11,600 ± 974 y = 1020x − 1850 0.82 Increasing 
PC_(36:2) 6650 ± 1180 7290 ± 1320 7890 ± 1490 10,700 ± 954 y = 472x + 4520 0.85 Increasing 
PC_(36:3) 8480 ± 912 9060 ± 1570 11,800 ± 1920 23,900 ± 2150 y = 1810x − 573 0.77 Increasing 
PC_(36:4) 18,900 ± 3120 20,200 ± 2700 19,500 ± 1190 27,500 ± 1900 y = 930x + 14400 0.65  
PC_(37:0) 0.557 ± 0.4 0.542 ± 0.232 0.338 ± 0.231 0.689 ± 0.551 y = 0.00711x + 0.477 0.03  
PC_(37:1) 40.9 ± 20.8 38 ± 19.4 75.1 ± 38.1 283 ± 96.2 y = 28.3x − 107 0.71  
PC_(37:2) 301 ± 88.2 217 ± 62.9 210 ± 61.6 301 ± 56.6 y = −0.259x + 259 0.00  
PC_(37:3) 83.4 ± 17.3 86.2 ± 25.1 131 ± 33.9 160 ± 31.9 y = 10.2x + 37.3 * 0.92 Increasing 
PC_(37:4) 2810 ± 648 3180 ± 738 2520 ± 674 2430 ± 461 y = −66.7x + 3250 0.47  
PC_(37:5) 157 ± 59.9 171 ± 36.4 270 ± 103 445 ± 77.3 y = 35.7x − 12.1 0.88 Increasing 
PC_(37:6) 85 ± 34.3 76 ± 37.5 55.8 ± 29.9 101 ± 29.7 y = 1.03x + 71.6 0.04  
PC_(38:0) 1.83 ± 0.323 1.77 ± 0.432 1.79 ± 0.773 2.67 ± 0.91 y = 0.0941x + 1.3 0.56  
PC_(38:1) 39.4 ± 20.9 14.1 ± 12.8 28.9 ± 21.3 103 ± 42.3 y = 7.61x − 11.9 0.46  
PC_(38:2) 649 ± 137 521 ± 186 493 ± 137 871 ± 171 y = 23.6x + 453 0.23  
PC_(38:3) 3030 ± 346 3260 ± 708 5020 ± 1050 12,200 ± 1770 y = 1080x − 2420 0.77 Increasing 
PC_(38:4) 10,300 ± 2010 11,700 ± 2240 10,200 ± 1090 12,100 ± 2290 y = 144x + 9970 0.27  
PC_(38:5) 6010 ± 2050 5500 ± 1900 5290 ± 916 8730 ± 1930 y = 294x + 4130 0.41  
PC_(38:6) 16,000 ± 3530 14,000 ± 1550 12,900 ± 1690 18,900 ± 2600 y = 281x + 13300 0.14  
PC_(40:2) 19.1 ± 8.48 14.8 ± 4.37 13.2 ± 3.21 20.1 ± 5.31 y = 0.0519x + 16.4 0.00  
PC_(40:3) 52.8 ± 15 44 ± 15.1 52.7 ± 13.6 124 ± 22.6 y = 8.23x + 5.39 0.59  
PC_(40:4) 1200 ± 402 884 ± 230 726 ± 182 665 ± 175 y = −65.3x + 1370 * 0.90 Decreasing 
PC_(40:5) 947 ± 577 704 ± 574 514 ± 208 980 ± 459 y = −3.37x + 812 0.00  
PC_(40:6) 3800 ± 936 3630 ± 913 3090 ± 720 4370 ± 960 y = 43.3x + 3390 0.08  
PC_C18(plas)-18:1 ND ± ND ND ± ND ND ± ND 0.766 ± 1.43    
PE_(30:0) 4.78 ± 10.7 2.19 ± 4.47 ND ± ND 1.82 ± 5.14 y = −0.323x + 5.26 0.68  
PE_(32:1) 12.4 ± 20.9 26 ± 38.5 468 ± 553 1920 ± 896 y = 228x − 1140 0.78 Increasing 
PE_(34:0) 80.3 ± 34.4 106 ± 24 54.8 ± 20.8 30.5 ± 35.6 y = −7.43x + 125 0.63  
PE_(34:1) 4110 ± 2220 4930 ± 1800 9030 ± 1940 18100 ± 6000 y = 1710x − 4010 0.86 Increasing 
PE_(34:2) 71,600 ± 27,000 69,300 ± 42,400 48,600 ± 14,200 29,500 ± 12,000 y = −5440x + 96400 * 0.92 Decreasing 
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PE_(35:1) 4.9 ± 2 10.6 ± 3.84 23.9 ± 7.89 42.4 ± 13 y = 4.66x − 15.2 * 0.95 Increasing 
PE_(36:0) 24.4 ± 11.3 35 ± 15 22.8 ± 6.68 17 ± 12.8 y = −1.27x + 34.5 0.35  
PE_(36:1) 6560 ± 4060 5730 ± 2600 6590 ± 1730 11,300 ± 4870 y = 559x + 3270 0.59  
PE_(36:2) 46,300 ± 18,900 36,900 ± 20,900 24,400 ± 6230 19,300 ± 7930 y = −3460x + 58200 * 0.98 Decreasing 
PE_(36:3) 39,000 ± 15,000 28,800 ± 17,100 20,000 ± 4520 14,300 ± 5490 y = −3070x + 49000 * 0.99 Decreasing 
PE_(36:4) 110,000 ± 44,700 107,000 ± 49,200 96,600 ± 12,500 126,000 ± 34,500 y = 1390x + 99,200 0.16  
PE_(38:1) 219 ± 130 144 ± 84.5 115 ± 22 121 ± 46.7 y = −12x + 241 0.76  
PE_(38:2) 1530 ± 645 822 ± 467 539 ± 98.4 535 ± 140 y = −121x + 1780 0.81 Decreasing 
PE_(38:3) 13400 ± 4930 13,000 ± 7700 14,400 ± 2710 17,700 ± 3860 y = 530x + 10,600 0.75  
PE_(38:4) 165,000 ± 74,800 148,000 ± 59,300 113,000 ± 20,200 118,000 ± 26,000 y = −6520x + 186,000 0.84  
PE_(38:5) 72,900 ± 38,400 52,700 ± 23,200 39,700 ± 7150 44,700 ± 11,600 y = −3610x + 80,200 0.74  
PE_(38:6) 25,000 ± 12,000 18200 ± 8270 12,300 ± 2890 19,100 ± 5400 y = −874x + 25,300 0.34  
PG_(32:0) 1.64 ± 0.748 1.59 ± 0.834 5.29 ± 4.05 11 ± 3.46 y = 1.18x − 4.12 0.86  
PG_(33:0) ND ± ND ND ± ND ND ± ND 0.0213 ± 0.0434    
PG_(34:1) ND ± ND ND ± ND 2.24 ± 3.19 65.1 ± 51.8 y = 23.3x − 207 1.00  
PG_(35:1) 0.256 ± 0.325 0.467 ± 0.67 0.816 ± 0.888 1.62 ± 0.913 y = 0.164x − 0.469 * 0.91 Increasing 
PG_(36:0) 11.8 ± 3.75 25.6 ± 18 13.4 ± 4.49 7.6 ± 5.1 y = −0.919x + 21.6 0.17  
PG_(36:1) 0.0408 ± 0.122 1.84 ± 2.72 0.525 ± 0.62 0.294 ± 0.831 y = −0.0206x + 0.832 0.01  
PG_(36:2) 125 ± 25.3 169 ± 81.3 106 ± 43.1 53.5 ± 21 y = −10.3x + 192 0.56  
PG_(36:3) 48.8 ± 14.2 62.3 ± 30 32.3 ± 9.53 28.1 ± 20.5 y = −3.41x + 69 0.57  
PG_(36:4) 25.6 ± 13.6 45.9 ± 26.9 33.6 ± 15.7 29.1 ± 15.4 y = −0.0667x + 34.1 0.00  
PG_(38:3) 1.72 ± 1.42 1.04 ± 0.753 3.19 ± 3.43 7.34 ± 3.64 y = 0.704x − 2.06 0.75  
PG_(38:4) 11.7 ± 5.76 19.5 ± 9.9 13.3 ± 5.22 11.9 ± 5.31 y = −0.207x + 15.7 0.04  
PG_(38:5) 6.31 ± 2.82 9.55 ± 5.47 6.6 ± 2.34 7.16 ± 4.03 y = −0.0148x + 7.52 0.00  
PG_(38:6) 0.0292 ± 0.0876 0.0656 ± 0.0754 0.0529 ± 0.067 0.0457 ± 0.0527 y = 0.00136x + 0.0379 0.10  
PG_(40:6) 0.306 ± 0.378 0.211 ± 0.434 0.028 ± 0.0792 0.773 ± 0.913 y = 0.0451x − 0.0156 0.25  
PG_(42:07) 0.469 ± 0.411 0.424 ± 0.714 0.269 ± 0.332 0.305 ± 0.316 y = −0.024x + 0.55 0.77  
PG_(42:08) 0.0147 ± 0.0192 0.0893 ± 0.11 0.112 ± 0.116 ND ± ND y = 0.018x − 0.0415 0.91 Increasing 
PG_(42:10) 0.0638 ± 0.191 0.314 ± 0.943 ND ± ND 0.0417 ± 0.118 y = -0.00954x + 0.209 0.07  
PI_(34:0) 455 ± 385 482 ± 396 354 ± 237 318 ± 196 y = −20x + 555 0.78  
PI_(34:1) 5070 ± 1420 5070 ± 909 7620 ± 1620 10,100 ± 2670 y = 653x + 1970 0.89  
PI_(34:2) 6510 ± 3850 9740 ± 4140 9450 ± 3880 3260 ± 1640 y = −372x + 10100 0.18  
PI_(35:0) 0.0814 ± 0.244 0.0917 ± 0.275 ND ± ND ND ± ND y = 0.00381x + 0.0677 1.00  
PI_(35:2) 134 ± 112 319 ± 164 261 ± 137 82.5 ± 68.9 y = −7.87x + 259 0.06  
PI_(36:1) 186 ± 165 450 ± 292 659 ± 339 814 ± 589 y = 77.5x − 65.8 * 0.99 Increasing 
PI_(36:2) 3680 ± 2670 5400 ± 2720 4920 ± 2300 2020 ± 1140 y = −202x + 5550 0.22  
PI_(36:4) 16,000 ± 6720 25,800 ± 10,600 27,900 ± 8740 21,000 ± 9500 y = 633x + 17,800 0.17  
PI_(38:3) 6340 ± 4020 10,500 ± 6710 14,200 ± 8060 6420 ± 3950 y = 146x + 8250 0.02  
PI_(38:4) 86,600 ± 41,000 124,000 ± 50,900 119,000 ± 34,000 79,600 ± 40,400 y = −963x + 110,000 0.02  
PI_(38:5) 11,100 ± 5400 15,000 ± 5750 16,600 ± 4890 12400 ± 5840 y = 204x + 12,200 0.08  
PI_(40:3) 120 ± 56.6 94 ± 51.8 49.8 ± 19 25.2 ± 8.08 y = −12.2x + 165 * 0.99 Decreasing 
PI_(40:4) 1040 ± 615 1830 ± 1050 1380 ± 608 885 ± 607 y = −33.9x + 1540 0.08  
PI_(40:6) 4080 ± 1020 5270 ± 1350 4820 ± 901 6870 ± 1270 y = 293x + 3020 0.75  
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PI_(40:8) 42.9 ± 25 48.9 ± 23.4 47.4 ± 22.1 50.8 ± 21 y = 0.822x + 41.2 0.72  
PS_(32:0) 0.673 ± 0.587 0.661 ± 0.918 0.321 ± 0.135 0.802 ± 0.336 y = 0.00174x + 0.601 0.00  
PS_(32:1) 0.00219 ± 0.00658 0.0339 ± 0.0329 0.00448 ± 0.0127 0.00374 ± 0.0106 y = −0.000917x + 0.0181 0.04  
PS_(33:1) 1.25 ± 0.504 1.76 ± 0.541 1.8 ± 0.553 1.19 ± 1.06 y = −0.00519x + 1.54 0.00  
PS_(34:0) 0.0337 ± 0.101 0.291 ± 0.452 0.16 ± 0.211 0.0675 ± 0.096 y = −0.0011x + 0.146 0.00  
PS_(34:1) ND ± ND 0.0315 ± 0.0945 ND ± ND 0.73 ± 0.911 y = 0.129x − 0.783 1.00  
PS_(34:2) 10.3 ± 4.05 13.8 ± 4.69 15.3 ± 4.34 11.7 ± 5.1 y = 0.211x + 11.2 0.11  
PS_(34:3) 0.051 ± 0.0821 0.0582 ± 0.115 0.202 ± 0.314 0.911 ± 0.888 y = 0.101x − 0.466 0.74 Increasing 
PS_(35:2) 0.215 ± 0.514 0.379 ± 0.946 0.0732 ± 0.207 0.101 ± 0.286 y = −0.024x + 0.376 0.36  
PS_(36:0) 0.242 ± 0.479 0.34 ± 0.527 0.261 ± 0.489 0.485 ± 0.672 y = 0.0241x + 0.148 0.58  
PS_(36:1) 63.9 ± 28.7 135 ± 76.6 101 ± 23.5 75.4 ± 43 y = 0.0185x + 93.7 0.00  
PS_(36:2) 115 ± 47 136 ± 51.5 123 ± 33.2 83 ± 23.2 y = −4.04x + 145 0.39  
PS_(38:2) 0.434 ± 0.578 1.66 ± 1.78 0.712 ± 0.42 0.536 ± 0.84 y = −0.0238x + 1.02 0.02  
PS_(38:5) ND ± ND 0.0745 ± 0.224 ND ± ND ND ± ND    
PS_(38:6) 113 ± 23.8 126 ± 29.7 140 ± 34.3 201 ± 55.3 y = 10.3x + 66.2 0.85 Increasing 
PS_(40:0) 0.352 ± 0.406 1.18 ± 0.599 0.755 ± 0.566 1.46 ± 0.838 y = 0.107x + 0.115 0.59  
PS_(40:2) 0.485 ± 1.31 1.23 ± 2.17 ND ± ND ND ± ND y = 0.276x − 0.508 1.00  
PS_(40:3) 215 ± 36.3 243 ± 49.1 206 ± 51.9 147 ± 28.2 y = −8.93x + 271 0.59  
PS_(42:6) 185 ± 75.9 262 ± 104 237 ± 95.8 87.8 ± 37.6 y = −11.7x + 283 0.28  
S_(32:0) 0.134 ± 0.0379 0.128 ± 0.0538 0.112 ± 0.0157 0.0075 ± 0.014 y = −0.0146x + 0.207 0.74 Decreasing 
S_(32:1) ND ± ND ND ± ND ND ± ND 0.000566 ± 0.0016    
S_(34:0) 1.04 ± 0.105 2.09 ± 1.77 1.54 ± 0.259 1.31 ± 0.586 y = 0.00963x + 1.42 0.01  
S_(34:1-OH) 1.47 ± 0.48 1.72 ± 0.795 1.08 ± 0.388 1.35 ± 0.9 y = −0.037x + 1.69 0.24  
S_(34:2) 0.592 ± 0.147 0.769 ± 0.36 0.402 ± 0.187 0.327 ± 0.128 y = −0.043x + 0.852 0.57  
S_(35:0) 0.0316 ± 0.0617 0.022 ± 0.0369 0.0626 ± 0.123 0.0338 ± 0.0371 y = 0.00175x + 0.0241 0.12  
S_(35:1) 0.0235 ± 0.041 0.021 ± 0.0344 0.0404 ± 0.0922 0.16 ± 0.307 y = 0.0159x − 0.0603 0.70  
S_(35:1-OH) 0.209 ± 0.281 0.127 ± 0.381 ND ± ND ND ± ND y = −0.0304x + 0.318 1.00  
S_(35:2) ND ± ND ND ± ND 0.00482 ± 0.00897 0.00385 ± 0.00881 y = −0.000359x + 0.00805 1.00  
S_(36:1) 0.999 ± 0.437 1 ± 0.661 0.824 ± 0.375 0.561 ± 0.391 y = −0.0552x + 1.27 0.86  
S_(37:2) 0.159 ± 0.092 0.296 ± 0.22 0.206 ± 0.125 0.08 ± 0.0753 y = −0.0121x + 0.278 0.22  
S_(38:0) 1.88 ± 0.631 3.39 ± 2.13 1.89 ± 0.684 1.03 ± 0.594 y = −0.15x + 3.2 0.28  
S_(38:1-OH) 0.153 ± 0.242 0.197 ± 0.308 0.116 ± 0.253 0.0765 ± 0.109 y = −0.0115x + 0.224 0.61  
S_(39:1) 0.111 ± 0.0948 0.41 ± 0.632 0.194 ± 0.249 0.0621 ± 0.12 y = −0.0134x + 0.297 0.09  
S_(40:0) 7.77 ± 1.43 17.9 ± 12.7 10.5 ± 4.51 7.67 ± 4.6 y = −0.285x + 13.1 0.04  
S_(40:1-OH) 1.48 ± 0.815 1.78 ± 1.37 1.57 ± 0.909 1.46 ± 1.39 y = −0.01x + 1.65 0.06  
S_(40:2) 1.04 ± 0.637 1.44 ± 0.841 1.03 ± 0.425 0.566 ± 0.349 y = −0.0679x + 1.54 0.44  
S_(41:0) 0.352 ± 0.195 1.1 ± 0.943 0.253 ± 0.162 0.0222 ± 0.0413 y = −0.068x + 0.952 0.26  
S_(41:2) ND ± ND 0.0108 ± 0.0324 0.021 ± 0.0318 0.0543 ± 0.0655 y = 0.00806x − 0.0438 0.91  
S_(42:0) 0.322 ± 0.225 0.59 ± 0.876 0.491 ± 0.223 0.294 ± 0.162 y = −0.00678x + 0.476 0.03  
S_(42:2) 0.395 ± 0.385 1.1 ± 1.26 0.958 ± 0.837 0.983 ± 0.763 y = 0.0601x + 0.399 0.44  
S_(42:2-OH) 2.43 ± 0.843 1.55 ± 0.588 0.786 ± 0.406 0.789 ± 0.434 y = −0.211x + 3 0.88  
S_(46:2-OH) 0.0599 ± 0.0337 0.0149 ± 0.0269 0.0228 ± 0.018 0.0258 ± 0.031 y = −0.0035x + 0.0576 0.37  
S_(48:2-OH) 0.00958 ± 0.0163 ND ± ND 0.00395 ± 0.00731 0.00115 ± 0.00326 y = −0.00104x + 0.0133 1.00  
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SM_(30:1) 1.61 ± 0.262 1.59 ± 0.611 1.89 ± 0.679 1.84 ± 0.667 y = 0.0367x + 1.45 0.68  
SM_(32:0) 4.99 ± 0.941 4.66 ± 2.13 3.81 ± 1.08 2.85 ± 1.21 y = −0.269x + 6.14 * 0.96 Decreasing 
SM_(32:1) 428 ± 88.3 368 ± 107 334 ± 87.3 256 ± 63.6 y = −20.4x + 502 * 0.98 Decreasing 
SM_(33:1) 273 ± 37.3 238 ± 62.2 168 ± 32.2 135 ± 44.4 y = −17.9x + 341 * 0.98 Decreasing 
SM_(34:0) 21.8 ± 5.98 26 ± 6.49 22.2 ± 6.65 18 ± 4.85 y = −0.563x + 26.3 0.36  
SM_(34:0-OH) 7.39 ± 2.3 5.26 ± 2.46 3.5 ± 1.7 1.4 ± 1.69 y = −0.731x + 9.98 * 1.00 Decreasing 
SM_(34:1) 3400 ± 495 3830 ± 796 3240 ± 427 2620 ± 346 y = −109x + 4100 0.57  
SM_(34:1-OH) 4.36 ± 1.63 10.1 ± 8 5.89 ± 3.22 2.74 ± 2.48 y = −0.336x + 8.34 0.14  
SM_(34:2) 397 ± 102 401 ± 106 320 ± 50.4 282 ± 94.6 y = −15.8x + 471 0.88  
SM_(34:2-OH) 4.44 ± 1.37 4.15 ± 1.73 3.2 ± 0.88 2.68 ± 0.928 y = −0.231x + 5.38 * 0.96 Decreasing 
SM_(35:0) 0.957 ± 1.35 0.969 ± 0.848 0.457 ± 0.267 0.389 ± 0.404 y = −0.0821x + 1.32 0.84  
SM_(35:1) 36.3 ± 3.74 48.6 ± 6.53 40.9 ± 7.5 41.1 ± 8.38 y = 0.248x + 39.8 0.03  
SM_(35:2) 0.632 ± 0.456 0.335 ± 0.314 0.144 ± 0.149 0.137 ± 0.18 y = −0.0621x + 0.787 0.87 Decreasing 
SM_(36:1) 449 ± 43.4 529 ± 103 446 ± 58.3 298 ± 50.5 y = −19.9x + 582 0.52  
SM_(36:2) 32 ± 6.24 38.6 ± 9.35 30.9 ± 4.52 23.1 ± 5.49 y = −1.27x + 40.9 0.49  
SM_(36:3) 2.19 ± 0.784 1.71 ± 0.891 0.76 ± 0.384 0.406 ± 0.326 y = −0.233x + 3.05 * 0.97 Decreasing 
SM_(37:2) 0.0328 ± 0.0984 0.024 ± 0.0721 ND ± ND 0.0197 ± 0.0556 y = −0.0015x + 0.0363 0.86  
SM_(38:0) 7.73 ± 1.45 7.83 ± 3.24 6.35 ± 1.81 4.64 ± 1.6 y = −0.398x + 9.68 0.86  
SM_(38:1) 342 ± 56.4 293 ± 59.3 200 ± 27.7 106 ± 19.4 y = −29.7x + 462 * 0.98 Decreasing 
SM_(39:0) 8.55 ± 3.43 8.71 ± 6.78 12.5 ± 7.79 ND ± ND y = 0.731x + 5.31 0.78 Increasing 
SM_(39:1) 178 ± 28.6 142 ± 35.5 109 ± 28.1 85.4 ± 10.7 y = −11.5x + 217 * 0.99 Decreasing 
SM_(40:0) 17.3 ± 5.88 14.2 ± 4.27 10.8 ± 2.35 4.03 ± 1.2 y = −1.6x + 23.8 * 0.96 Decreasing 
SM_(40:0-OH) 5.96 ± 1.62 4.29 ± 1.17 3.53 ± 1.12 0.919 ± 0.868 y = −0.588x + 8.17 * 0.95 Decreasing 
SM_(40:1) 989 ± 137 867 ± 181 704 ± 125 520 ± 71.7 y = −58.1x + 1210 * 0.99 Decreasing 
SM_(40:2) 138 ± 21.3 123 ± 21.6 91.7 ± 16.9 55.3 ± 11.1 y = −10.3x + 181 * 0.97 Decreasing 
SM_(41:0) 8.36 ± 2.45 8.68 ± 2.13 7.03 ± 1.56 5.33 ± 1.63 y = −0.398x + 10.4 0.83  
SM_(41:1) 893 ± 123 839 ± 144 772 ± 135 695 ± 133 y = −24.5x + 987 * 0.99 Decreasing 
SM_(42:0) 8.67 ± 2.47 10.5 ± 3.94 7.13 ± 2.87 3.17 ± 1.49 y = −0.736x + 13 0.68  
SM_(42:0-OH) 12.7 ± 2.47 11.1 ± 1.98 9.01 ± 2.88 4.92 ± 1.53 y = −0.942x + 16.6 * 0.95 Decreasing 
SM_(42:1) 1610 ± 185 1540 ± 227 1280 ± 206 1020 ± 194 y = −75.2x + 1940 * 0.95 Decreasing 
SM_(42:2) 1160 ± 180 1180 ± 185 1010 ± 197 880 ± 109 y = −37.4x + 1340 0.86  
SM_(43:0) 0.202 ± 0.119 0.527 ± 0.275 0.368 ± 0.199 0.115 ± 0.152 y = −0.0156x + 0.422 0.09  
SM_(43:1) 158 ± 43.1 200 ± 35.8 163 ± 44.2 153 ± 57 y = −1.93x + 183 0.10  
SM_(44:1) 13.5 ± 4.24 17.9 ± 3.6 14.1 ± 4.99 9.32 ± 3.95 y = −0.605x + 18.3 0.36  
SM_(44:2) 27 ± 6.17 29.6 ± 5.31 27 ± 7.84 23.1 ± 5.83 y = −0.53x + 30.7 0.47  
TG_(18:0) 11 ± 8.91 11.3 ± 4.51 6.54 ± 4.04 2.47 ± 2.6 y = −1.12x + 16.4 0.88  
TG_(24:0) 920 ± 2500 39.9 ± 59.6 84.9 ± 195 177 ± 372 y = −80.9x + 924 0.46  
TG_(36:0) 170 ± 214 52.4 ± 36.9 93.4 ± 83.8 441 ± 288 y = 31.6x − 52.8 0.40  
TG_(44:1) 970 ± 941 325 ± 175 1550 ± 2130 2250 ± 1250 y = 188x − 161 0.63  
TG_(45:1) 14.3 ± 19 7.72 ± 5.87 32.3 ± 32.3 83.7 ± 49.3 y = 8.62x − 31.4 0.76  
TG_(45:2) 92.6 ± 86.2 31.6 ± 14.8 64.1 ± 58.7 84.2 ± 53.8 y = 0.27x + 66.1 0.00  
TG_(46:1) 85.4 ± 104 22.5 ± 16.1 87.6 ± 112 269 ± 189 y = 22.8x − 58.4 0.56  
TG_(46:2) 1060 ± 1040 293 ± 167 412 ± 311 787 ± 609 y = -25.9x + 836 0.07  
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TG_(46:4) 3530 ± 3550 700 ± 350 464 ± 357 316 ± 241 y = −366x + 4050 0.70 Decreasing 
TG_(47:0) 7.11 ± 7 2.59 ± 2.23 2.86 ± 4.1 6.91 ± 2.88 y = −0.0122x + 4.96 0.00  
TG_(47:1) 1.39 ± 3.19 0.253 ± 0.76 6.65 ± 10.2 19.6 ± 9.01 y = 2.26x − 10.3 0.79  
TG_(47:2) 11.5 ± 11.3 3.39 ± 2.87 10.9 ± 6.94 22.3 ± 17.7 y = 1.48x + 0.715 0.44  
TG_(48:0) 133 ± 69.6 63 ± 10.9 75.7 ± 98.4 92.4 ± 43.9 y = −4.04x + 122 0.21  
TG_(48:1) 142 ± 100 83 ± 29.2 279 ± 343 435 ± 172 y = 39.8x − 69.8 0.78  
TG_(48:2) 241 ± 196 115 ± 38.3 319 ± 401 440 ± 165 y = 29.7x + 51.8 0.57  
TG_(48:3) 250 ± 185 83.7 ± 27 112 ± 80.1 102 ± 49.9 y = −15.4x + 255 0.49  
TG_(49:0) 18 ± 9.16 10.7 ± 2.12 11 ± 5.69 10.2 ± 3.69 y = −0.856x + 19 0.65  
TG_(49:1) 35.7 ± 18.6 28.3 ± 9.67 67.9 ± 55.5 96.3 ± 30.3 y = 8.2x − 5.68 0.83  
TG_(49:2) 70.2 ± 29.8 50.1 ± 12.1 77.6 ± 55.4 86.3 ± 30.3 y = 2.81x + 49.6 0.40  
TG_(49:3) 27.3 ± 12.9 18.2 ± 5.03 26.8 ± 15.4 19.3 ± 7.36 y = −0.57x + 27.3 0.17  
TG_(50:0) 178 ± 68.6 118 ± 20.3 125 ± 57.6 102 ± 37.6 y = −8.19x + 193 0.75  
TG_(50:1) 1440 ± 548 1030 ± 339 1870 ± 1370 1870 ± 858 y = 78.9x + 949 0.47  
TG_(50:2) 2750 ± 1210 1830 ± 458 2920 ± 2200 2920 ± 1010 y = 59.3x + 2150 0.16  
TG_(50:3) 1500 ± 858 1050 ± 283 1760 ± 1370 1040 ± 452 y = −24.8x + 1530 0.06  
TG_(51:1) 79 ± 30.9 78.4 ± 31.8 138 ± 102 124 ± 39.6 y = 7.21x + 49.7 0.67  
TG_(51:2) 296 ± 163 274 ± 82.5 532 ± 293 509 ± 148 y = 33.2x + 149 0.72  
TG_(51:3) 648 ± 459 467 ± 133 437 ± 175 186 ± 86.3 y = −52.4x + 836 * 0.92 Decreasing 
TG_(51:4) 662 ± 568 330 ± 121 150 ± 55.5 37.2 ± 17.5 y = −76.1x + 877 * 0.94 Decreasing 
TG_(52:0) 128 ± 70.4 80.4 ± 17.6 69.5 ± 28.8 47.4 ± 24.1 y = −9.36x + 153 * 0.92 Decreasing 
TG_(52:1) 849 ± 304 716 ± 311 1130 ± 904 823 ± 275 y = 12.4x + 784 0.06  
TG_(52:2) 12,300 ± 6460 9670 ± 3230 12700 ± 6000 8610 ± 3300 y = −298x + 13100 0.27  
TG_(52:3) 36,800 ± 25,800 22,700 ± 5870 15,800 ± 5770 5160 ± 2670 y = −3770x + 49000 * 0.98 Decreasing 
TG_(52:4) 45,200 ± 36,700 21,100 ± 7240 9760 ± 3330 2220 ± 1880 y = −5200x + 59300 * 0.93 Decreasing 
TG_(53:1) 28.5 ± 8.42 23.8 ± 10.3 36.4 ± 29.3 25.5 ± 8.57 y = 0.133x + 27.5 0.01  
TG_(53:2) 253 ± 129 240 ± 109 353 ± 259 214 ± 67.8 y = −0.148x + 266 0.00  
TG_(53:3) 801 ± 527 518 ± 145 470 ± 175 183 ± 73.3 y = −70.4x + 1030 * 0.94 Decreasing 
TG_(53:4) 877 ± 722 489 ± 180 277 ± 100 75.2 ± 38.5 y = −96.9x + 1170 * 0.97 Decreasing 
TG_(54:0) 20.1 ± 12.8 11.5 ± 2.27 9.51 ± 3.73 7.25 ± 5.07 y = −1.5x + 23.6 0.87 Decreasing 
TG_(54:1) 117 ± 54.8 79 ± 24.1 96.6 ± 86.6 57.2 ± 25.8 y = −5.99x + 133 0.67  
TG_(54:2) 866 ± 326 637 ± 373 805 ± 731 408 ± 146 y = −44.7x + 1020 0.58  
TG_(54:3) 5400 ± 3270 2880 ± 1140 2350 ± 1060 1000 ± 436 y = −509x + 6800 * 0.93 Decreasing 
TG_(54:4) 14,200 ± 10,600 6230 ± 2180 3450 ± 1230 977 ± 444 y = −1570x + 18,200 * 0.91 Decreasing 
TG_(54:5) 26,100 ± 21,100 10,200 ± 4050 4300 ± 1350 1010 ± 595 y = −3010x + 33,400 0.89 Decreasing 
TG_(54:6) 24,900 ± 20,300 9310 ± 3280 2980 ± 1090 554 ± 426 y = −2940x + 31,900 0.88 Decreasing 
TG_(55:2) 13.8 ± 4.81 9.88 ± 6.38 16.2 ± 17.2 8.35 ± 3.23 y = −0.371x + 14.9 0.13  
TG_(55:3) 77.5 ± 39.7 46.2 ± 18.2 44.1 ± 29.4 19.7 ± 8.29 y = −6.5x + 96.6 * 0.91 Decreasing 
TG_(55:4) 142 ± 102 65.1 ± 25.8 44.9 ± 20.2 10.8 ± 6.06 y = −15.3x + 183 * 0.92 Decreasing 
TG_(55:5) 161 ± 137 92.4 ± 44 49.8 ± 23.4 14.4 ± 11 y = −17.9x + 216 * 0.98 Decreasing 
TG_(55:6) 122 ± 143 100 ± 46.1 50.3 ± 18.8 8.95 ± 8.19 y = −14.4x + 180 * 0.98 Decreasing 
TG_(56:2) 31.6 ± 11.6 20.8 ± 10.4 30.9 ± 40 11.7 ± 4.55 y = −1.84x + 37.8 0.46  
TG_(56:3) 189 ± 87.4 100 ± 43.6 93.3 ± 74.8 31.4 ± 14.6 y = −17.8x + 239 * 0.91 Decreasing 
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TG_(56:6) 6970 ± 6060 3330 ± 1460 1200 ± 414 246 ± 173 y = −826x + 9260 * 0.93 Decreasing 
TG_(56:7) 8570 ± 7750 3690 ± 1650 1190 ± 519 282 ± 194 y = −1010x + 11,200 * 0.90 Decreasing 
TG_(56:8) 7360 ± 7600 2990 ± 1460 893 ± 372 186 ± 119 y = −875x + 9550 0.89 Decreasing 
TG_(57:2) 0.611 ± 0.405 0.434 ± 0.601 1 ± 1.89 0.371 ± 0.399 y = −0.0057x + 0.648 0.00  
TG_(57:6) 83.1 ± 100 39.6 ± 24.4 16.6 ± 3.26 5.21 ± 5.03 y = −9.51x + 109 * 0.93 Decreasing 
TG_(58:10) 1370 ± 1470 564 ± 268 161 ± 77.3 29.9 ± 23.1 y = −164x + 1780 0.90 Decreasing 
TG_(58:7) 1160 ± 1150 484 ± 241 123 ± 65.2 20 ± 18.1 y = −140x + 1520 0.90 Decreasing 
TG_(58:8) 1600 ± 1440 654 ± 354 186 ± 77.9 42.6 ± 30.7 y = −190x + 2080 0.89 Decreasing 
TG_(58:9) 1730 ± 1730 730 ± 418 206 ± 106 41.2 ± 28.3 y = −207x + 2260 0.90 Decreasing 
TG_(59:3) 0.283 ± 0.273 0.333 ± 0.708 0.539 ± 1.26 0.0277 ± 0.0537 y = −0.0207x + 0.454 0.12  
TG_(59:4) 0.348 ± 0.474 0.22 ± 0.449 0.372 ± 0.807 0.00429 ± 0.0121 y = −0.0326x + 0.485 0.45  
TG_(59:5) 0.212 ± 0.241 0.104 ± 0.128 ND ± ND ND ± ND y = −0.04x + 0.356 1.00  
TG_(59:6) 0.382 ± 0.578 0.178 ± 0.227 0.137 ± 0.174 0.108 ± 0.197 y = −0.032x + 0.446 0.81 Decreasing 
TG_(59:7) 0.214 ± 0.434 0.147 ± 0.232 ND ± ND 0.0326 ± 0.0607 y = −0.0222x + 0.291 1.00  
TG_(59:8) 9.09 ± 14.6 6.77 ± 11.9 5.83 ± 9.99 1.75 ± 2.04 y = −0.85x + 12.4 * 0.94 Decreasing 
TG_(60:10) 194 ± 194 73.7 ± 56.6 4.21 ± 4.15 0.838 ± 1.23 y = −24x + 252 0.86 Decreasing 
TG_(60:12) 79.5 ± 74.4 39.6 ± 28 13 ± 12.1 1.42 ± 2.02 y = −9.66x + 107 * 0.94 Decreasing 
TG_(62:12) 63.3 ± 43.7 31.3 ± 17.4 11 ± 5.05 0.863 ± 0.716 y = −7.69x + 85.4 * 0.95 Decreasing 
TG_(62:13) 4.22 ± 2.92 2.86 ± 3.13 0.546 ± 1.15 0.0336 ± 0.0949 y = −0.551x + 6.13 * 0.95 Decreasing 
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3. Discussion 
Out of 472 lipids detected and semi-quantified, 100 showed a strong relationship with the 
dietary intake of ruminant fat with 35 species increasing and 65 species decreasing as the percentage 
of ruminant fat in the diet increased (NB. ruminant fat as a percentage composition with corn-oil and 
medium chain triacylglyceride oil). Interestingly, ceramides generally increased, whilst cardiolipins, 
sphingomyelins and triacylglycerides generally decreased as the dietary composition of ruminant fat 
rose. According to the literature, a rise in liver ceramides is typically associated with aggravated non-
alcoholic fatty liver disease (NAFLD) and insulin resistance [23], this in conjunction with a decrease 
in cardiolipins (which are indicative of mitochondrial remodelling and dysfunction [24]) may suggest 
that the changes in the experimental diets here are detrimental for these pathologies. However, there 
was a clear decrease in the triacylglycerides (particularly evident in the unsaturated odd chain 
triacylglycerides), which is explicitly representative of an ameliorated pathology [25]. As previously 
published [26], many NAFLD and insulin resistance factors were mitigated as the ruminant fat 
increased in these diets, including: a reduction in the total body weight (g), total fat mass (%), serum 
ALT (U/mL) and degree of steatosis determined by Oil Red O staining, notably, the inflammatory 
marker TNFα did not change significantly (trend: p-value = 0.52). A key characteristic of NAFLD 
development is the accumulation of hepatic triacylglycerides [27]; therefore, the data here suggests 
that these dietary changes may be beneficial for NAFLD and insulin resistance by aiding in a reduced 
hepatic triacylglyceride load: possible mechanisms here include a lower saturated fatty acid 
composition resulting in a lower fatty acid incorporation into hepatic triacylglycerides and/or a 
higher pass-through of the medium chain triglyceride oil directly into the mitochondria stimulation 
fatty acid metabolism [26]. Work presented by Gonzalez-Cantero and colleagues [28] showed that 
hepatic triacylglyceride content were correlated with insulin resistance and these relationships were 
independently to the inflammatory marker TNFα. Therefore, it appears that the hepatic 
triacylglyceride load may be paramount in the development of NAFLD and insulin resistance, which 
is supported in the literature [29]. 
According to the literature, odd chain fatty acids are considered biomarkers of their dietary 
intake and particularly accredited as a biomarkers of ruminant fat intake (e.g., milk, butter and beef 
tallow, etc.); however, there is a vast amount of conflicting data [2]. Some studies have shown both 
positive correlations (either individual odd chain lipids or total odd chain lipids) and some studies 
have shown there were no significant correlations. Although these studies may conflict in their 
findings they all present their data as relative compositions (Mol%), which is the typical way lipid 
data appear in the literature [30]. By expressing the lipid data as relative compositions (Mol%), it 
normalises the data to the total fat in that sample; however, presenting the lipid data in this way 
confounds the results by interconnecting the individual data points. This interconnection can cause 
false positive and/or false negative conclusions (type 1 and 2 errors), i.e., if a single lipid increases it 
will artificially decrease the other(s) due to the Mol% calculation. As shown in the figure below (see 
Figure 2), the concentration of the total lipids containing either even chain or odd chain fatty acids 
and a combination are shown. Although lipids containing odd chain fatty acids did increase, albeit 
not statistically significantly; p value: 0.197, it was also not proportionate to the increase in dietary 
ruminant fat. As shown, the lipids containing even chain fatty acids did significantly inversely 
decrease (slope p-value: 0.0189) as the dietary ruminant fat increased. Interestingly, due to both the 
decrease in the even chain lipids and the consistency of the odd chain lipids, if the relative 
composition (Mol%) of the lipids were calculated, there appears to be a statistically significant 
increase in the odd chain lipids (see Figure 3); however, this is an artefact of changes in the even chain 
lipids and a consequence of interconnecting the data. 
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Figure 2. This figure shows the change in the liver lipid concentrations across the four high-fat diets 
fed to Sprague–Dawley rats (n = 8–9 per group): total odd chain lipids (symbol: X, trendline: , 
gradient: 0.183 ± 0.0962, R2 = 0.64, slope significance p-value: 0.197); total even chain lipids (symbol: 
, trendline: , gradient: −41.0 ± 5.71, R2 = 0.963, slope significance p value: 0.0189); total lipids 
containing both even and of odd chain (symbol: O, trendline: , gradient: −40.8 ± 5.79, R2 = 0.961, 
slope significance p-value: 0.0195. Lipid concentrations (µM/mg) are shown as means ± standard 
deviation and were extracted via the protein precipitation liquid extraction protocol (chloroform: 
methanol: acetone, ~7:3:4). 
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Figure 3. This figure shows the relative compositional (Mol%) change in the total odd chain lipids 
(symbol: X, trendline: , gradient: 0.0604 ± 0.00203, R2 = 0.998, slope significance p value: 0.0011) 
and the total even chain lipids (symbol: , trendline: , gradient: −0.0604 ± 0.00203, R2 = 0.998, 
slope significance p-value: 0.0011) across the four high-fat diets in Sprague–Dawley rats (n = 8–9 per 
group). Lipid compositions (Mol%) are shown as means ± standard deviation and were extracted via 
the protein precipitation liquid extraction protocol (chloroform: methanol: acetone, ~7:3:4). Diet one: 
3.6% beef tallow; diet two: 6.3% beef tallow; diet three: 9.0% beef tallow; diet four: 11.7% beef tallow. 
4. Materials and Methods 
4.1. Chemicals and Standards 
Stable isotope-labelled internal standards purchased from Sigma Aldrich (Haverhill, Suffolk, 
UK) include: N-palmitoyl-d31-D-erythro-sphingosine (abbreviated to IS_Cer_16:0-d31); order 
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number: 868516P, 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphate (abbreviated to IS_PA_34:1-d31); 
order number: 860453P, 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphocholine (abbreviated to 
IS_PC_34:1-d31); order number: 860399P, 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-
phosphoethanolamine (abbreviated to IS_PE_34:1-d31); order number: 860374P, 1-palmitoyl-d31-2-
oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (abbreviated to IS_PG_34:1-d31); order number: 
860384P, 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphoinositol (abbreviated to IS_PI_34:1-d31); 
order number: 860042P, 1,2-dimyristoyl-d54-sn-glycero-3-[phospho-L-serine] (abbreviated to 
IS_PS_28:0-d54); order number: 860401P, N-palmitoyl-d31-D-erythro-sphingosylphosphorylcholine 
(abbreviated to IS_SM_34:1-d31); order number: 868584P. Stable isotope-labelled internal standards 
purchased from QMX Laboratories Ltd. (QMX Laboratories Ltd., Thaxted, Essex, UK) include: 
Heptadecanoic-d33 acid (abbreviated to IS_FA_17:0-d33); order number: D-5261, N-
tetradecylphosphocholine-d42 (abbreviated to IS_LPC_14:0-d42); order number: D-5885, Glyceryl 
tri(pentadecanoate-d29) (abbreviated to IS_TG_45:0-d87); order number: D-5265, Butyryl-d7-L-
carnitine (abbreviated to IS_Car_4:0-d7); order number: D-7761, Hexadecanoyl-L-carnitine-d3 
(abbreviated to IS_Car_16:0-d3); order number: D-6646. 
Quality control standards (LIPID-QC) purchased from Cayman Chemical Company (Cambridge 
Bioscience, Cambridge, UK) include: Lysophosphatidylcholines (egg); order number: 24331, 
Phosphotidylcholines (egg); order number: 24343, Lysophosphatidylethanolamines (egg); order 
number: 25844, Phosphatidylethanolamines (bovine); order number: 16878, 
Phosphotidlethanolamine (soy); order number: 25845, Lysophosphatidyinositols (porcine liver); 
order number: 26016, Phosphatidylserines (soy); order number: 25847, Ceramides mixture; order 
number: 22853, Ceramides (non-hydroxy); order number: 24833, Ceramides (hydroxy); order 
number: 24834, Sphingomyelins (from bovine spinal cord); order number: 22674, Sphingomylins 
(egg); order number: 24345, Phosphatidylglycerols (egg); order number: 25846, Phosphatidic acid 
(egg); order number: 24344, Sulfatides (bovine); order number: 24323, Purified mixed gangliosides 
(bovine); order number: 24856, TLC Neutral Glycosphingolipid Mixture (bovine and porcine); order 
number: 1505, 2-Palmitoyl Glycerol; order number: CAY17882, 1,2-Dipalmitoyl-sn-glycerol; order 
number: CAY10008648. Quality control standards purchased from Sigma Aldrich include: Soy PC 
(95%); order number: 441601G, C18(Plasm)-18:1-PC; order number: 852467C, Brain CPE; order 
number: 860066P, Liver PI; order number: 840042P, Brain lyso PS; order number: 850092P, Milk SM 
Sphingomyelin (Milk, Bovine); order number: 860063P, Galactocerebrosides from bovine brain; order 
number: C4905, Glucosylceramide (Soy); order number: 131304P, Triglyceride mix, C2–C10; order 
number: 17810-1amp-s, Fish oil from menhaden; order number: F8020, Anhydrous butter fat, 
Cardiolipin solution from bovine heart; order number: C1649, Brain PI(4)P; order number: 840045P. 
Commercially available blank human serum was purchased from BioIVT (Royston, 
Hertfordshire, UK; order number: HUMANSRMPNN. All solvents and additives were of HPLC 
grade or higher and purchased from Sigma Aldrich unless otherwise stated. 
LIPID-IS: the lipid stable isotope-labelled internal standard was prepared by dissolving each of 
the individual lipid standards into chloroform: methanol (1:1) solution to produce a 1 mM primary 
stock solution. From each of these stock solutions, 1 mL was transferred into a volumetric flask and 
diluted with methanol to reach a final working solution concentration of 5 µM in methanol of 
IS_Cer_16:0-d31, IS_FA_17:0-d33, IS_LPC_14:0-d42, IS_PA_34:1-d31, IS_PC_34:1-d31, IS_PE_34:1-
d31, IS_PG_34:1-d31, IS_PI_34:1-d31, IS_PS_28:0-d54, IS_SM_34:1-d31, IS_TG_45:0-d87. 
ACYL-CARNITINE-IS: the acyl-carnitine stable isotope-labelled internal standard was prepared 
by dissolving each powdered stock into methanol to achieve a 5 mM stock solution. Taking 1 mL of 
the IS_Car_4:0-d7 and IS_Car_16:0-d3 stock solutions and diluting these into methanol until a final 
working solution of 5 µM was achieved for IS_Car_4:0-d7 and IS_Car_16:0-d3. 
LIPID-QC: the lipid quality control standards were prepared by diluting each lipid mix to 
achieve a 50 µg/mL working stock solution in propan-2-ol: acetonitrile: water (2:1:1, respectively). 
4.2. Extraction 
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Lipids were isolated comparing two methods; firstly, a novel protein-precipitation liquid 
extraction and secondly the liquid–liquid extraction previously described by Folch and colleagues 
[12] in an adapted version as we described previously [31]. Tissue quantities ranged from ~2–50 mg 
and fluid samples from 10–50 µL (e.g., plasma/serum) were tested (data not shown here). 
4.2.1. Protein Precipitation Liquid Extraction Protocol (PPLE) 
The protein-precipitation liquid extraction protocol was as follows: the tissue samples were 
weighed (NB. fluid samples were pipetted) and transferred into a 2 mL screw cap Eppendorf plastic 
tube (Eppendorf, Stevenage, UK) along with a single 5 mm stainless steel ball bearing. Immediately, 
400 µL of chloroform: methanol (2:1, respectively) solution was added to each sample, followed by 
thorough mixing. The samples were then homogenised in the chloroform: methanol (2:1, 
respectively) using a Bioprep 24-1004 homogenizer (Allsheng, Hangzhou, China) run at speed; 4.5 
m/s, time; 30 s for 2 cycles. Then, 400 µL of chloroform, 100 µL of the LIPID-IS (5 µM in methanol) 
and 100 µL of the CARNITINE-IS (5 µM in methanol) was added to each sample. The samples were 
homogenised again using a Bioprep 24-1004 homogenizer run at speed; 4.5 m/s, time; 30 s for 2 cycles. 
To ensure fibrous material was diminished, the samples were sonicated for 30 min in a water bath 
sonicator (Advantage-Lab, Menen, Belgium). Then, 400 µL of acetone was added to each sample. The 
samples were thoroughly vortexed and centrifuged for 10 min at ~20,000× g to pellet any insoluble 
material at the bottom of the vial. The single layer supernatant was pipetted into separate 2 mL screw 
cap amber-glass auto-sampler vials (Agilent Technologies, Cheadle, UK); being careful not to break 
up the solid pellet at the bottom of the tube. The organic extracts (chloroform, methanol, acetone 
composition, ~1.4 mL) were dried down to dryness using a Concentrator Plus system (Eppendorf, 
Stevenage, UK) run for 60 min at 60 °C. The samples were reconstituted in 100 µL of 2:1:1 
(propan-2-ol, acetonitrile and water, respectively) then thoroughly vortex. The reconstituted sample 
was transferred into a 250 µL low-volume vial insert inside a 2 mL amber glass auto-sample vial 
ready for liquid chromatography with mass spectrometry detection (LC–MS) analysis. 
4.2.2. Folch Liquid–Liquid Extraction Protocol (Folch LLE) 
The Folch liquid–liquid extraction protocol is as follows: the tissue samples were weighed (NB. 
fluid samples were pipetted) and transferred into a 2 mL screw cap Eppendorf plastic tube 
(Eppendorf, Stevenage, UK) along with a single 5 mm stainless steel ball bearing. Immediately, 400 
µL of chloroform: methanol (2:1, respectively) solution was added to each sample, followed by 
thorough mixing. The samples were then homogenised in the chloroform: methanol (2:1, 
respectively) using a Bioprep 24-1004 homogenizer (Allsheng, Hangzhou, China) run at speed; 4.5 
m/s, time; 30 s for 2 cycles. Then, 400 µL of chloroform, 100 µL of the LIPID-IS (5 µM in methanol) 
and 100 µL of the ACYL-CARNITINE-IS (5 µM in methanol) was added to each sample. The samples 
were homogenised again using a Bioprep 24-1004 homogenizer run at speed; 4.5 m/s, time; 30 s for 2 
cycles. To ensure fibrous material was diminished, the samples were sonicated for 30 min in a water 
bath sonicator. Then, 400 µL of HPLC water was added to each samples. The samples were 
thoroughly vortexed and centrifuged for 10 min at ~20,000 g to separate the two immiscible fractions. 
The organic fractions (the lower layer, mostly chloroform; ~700 µL) and aqueous fractions (the upper 
layer, methanol and water; ~700 µL) were pipetted into separate 2 mL screw cap amber-glass auto-
sampler vials (Agilent Technologies, Cheadle, UK); being careful not to break up the solid pellet 
between the layers. To ensure complete lipid isolation a double extraction protocol was followed; 1 
mL of chloroform: methanol (2:1, respectively) solution was added to each sample, along with 400 
µL of HPLC water. The samples were thoroughly vortexed and centrifuged for 10 min at ~20,000× g. 
The organic fractions and aqueous fractions were pipetted into the corresponding 2 mL screw cap 
amber-glass auto-sampler vials containing the initial extracts (again being careful not to break up the 
solid pellet between the layers). The combined organic extracts (~1.4 mL) were dried down to dryness 
using a Concentrator Plus system (Eppendorf, Stevenage, UK) run for 60 min at 60 °C. The samples 
were reconstituted in 100 µL of 2:1:1 (propan-2-ol, acetonitrile and water, respectively) then 
thoroughly vortex. The reconstituted sample was transferred into a 250 µL low-volume vial insert 
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inside a 2 mL amber glass auto-sample vial ready for liquid chromatography with mass spectrometry 
detection (LC–MS) lipidomics analysis. 
4.3. LC–MS Method 
Full chromatographic separation of intact lipids was achieved using a Shimadzu HPLC System 
(Shimadzu UK Limited, Milton Keynes, UK) with the injection of 10 µL onto a Waters Acquity UPLC® 
CSH C18 column (Waters, Hertfordshire, UK); 1.7 µm, I.D. 2.1 mm × 50 mm, maintained at 55 °C. 
Mobile phase A was 6:4, acetonitrile and water with 10 mM ammonium formate. Mobile phase B was 
9:1, propan-2-ol and acetonitrile with 10 mM ammonium formate. The flow was maintained at 500 
µL per minute through the following gradient: 0.00 minutes_40% mobile phase B; 0.40 min_43% 
mobile phase B; 0.45 min_50% mobile phase B; 2.40 min_54% mobile phase B; 2.45 min_70% mobile 
phase B; 7.00 min_99% mobile phase B; 8.00 min_99% mobile phase B; 8.3 min_40% mobile phase B; 
10 min_40% mobile phase B. The sample injection needle was washed using 9:1, 2-propan-2-ol and 
acetonitrile. The mass spectrometer used was the Thermo Scientific Exactive Orbitrap with a heated 
electrospray ionisation source (Thermo Fisher Scientific, Hemel Hempstead, UK). The mass 
spectrometer was calibrated immediately before sample analysis using positive and negative 
ionisation calibration solution (recommended by Thermo Scientific). Additionally, the heated 
electrospray ionisation source was optimised at 50:50 mobile phase A to mobile phase B for spray 
stability (capillary temperature; 300 °C, source heater temperature; 420 °C, sheath gas flow; 40 
(arbitrary), auxiliary gas flow; 15 (arbitrary), spare gas; 3 (arbitrary), source voltage; 4 kV. The mass 
spectrometer scan rate set at 4 Hz, giving a resolution of 25,000 (at 200 m/z) with a full-scan range of 
m/z 100 to 1800 with continuous switching between positive and negative mode.  
4.4. Data Processing 
Thermo Xcalibur Quan Browser (Thermo Fisher Scientific, Hemel Hempstead, UK) data 
processing involved the integration of the internal standard extracted ion chromatogram (EIC) peaks 
at the expected retention times (see Table 2). The EIC were selected from the ionisation mode for each 
analyte class; the ionisation mode is dependent on the molecular chemistry of the analytes, i.e., basic 
chemical groups ordinarily result in positive ionisation (e.g., [M+H]+, M+H-H2O]+, [M+Na]+, 
[M+NH4]+, [M+K]+) whereas acidic chemical groups typically result in negative ionisation (e.g., 
[M-H]−). 
Table 2. This table shows the stable isotope-labelled internal standards with their ionisation products 
(i.e., [M+H]+, M+H-H2O]+, [M+Na]+, [M+NH4]+, [M+K]+, [M-H]−) and primary ionisation mode 
(positive; +ve or negative; -ve), along with their retention time (minutes). Butyryl-d7-L-carnitine 
(abbreviated to IS_Car_4:0-d7), N-tetradecylphosphocholine-d42 (abbreviated to IS_LPC_14:0-d42), 
hexadecanoyl-L-carnitine-d3 (abbreviated to IS_Car_16:0-d3), heptadecanoic-d33 acid (abbreviated to 
IS_FA_17:0-d33), 1,2-dimyristoyl-d54-sn-glycero-3-[phospho-L-serine] (abbreviated to IS_PS_28:0-
d54), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphoinositol (abbreviated to IS_PI_34:1-d31), N-
palmitoyl-d31-D-erythro-sphingosylphosphorylcholine (abbreviated to IS_SM_34:1-d31), 1-
palmitoyl-d31-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (abbreviated to IS_PG_34:1-d31), 1-
palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphate (abbreviated to IS_PA_34:1-d31), N-palmitoyl-d31-
D-erythro-sphingosine (abbreviated to IS_Cer_16:0-d31), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-
phosphocholine (abbreviated to IS_PC_34:1-d31), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-
phosphoethanolamine (abbreviated to IS_PE_34:1-d31), glyceryl tri(pentadecanoate-d29) 
(abbreviated to IS_TG_45:0-d87). 
Internal 
Standard 
Ionisation Product (m/z) 
Ionisation 
Mode 
Expected 
Retention Time 
(mins) 
IS_Car_4:0-d7 239.1983 +ve 0.3 
IS_LPC_14:0-
d42 
422.5560, 421.5498, 420.5435 +ve 0.4 
IS_Car_16:0-d3 403.3610 +ve 0.5 
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IS_FA_17:0-
d33 
302.4557, 301.4495, 300.4432 -ve 1.1 
IS_PS_28:0-
d54 
732.7741, 731.7678, 730.7615, 729.7553, 728.7490 -ve 1.4 
IS_PI_34:1-d31 864.7162, 865.7225, 866.7288 -ve 2.9 
IS_SM_34:1-
d31 
733.7632, 734.7670, 755.7451, 756.7514, 771.7190, 772.7253 +ve 3.0 
IS_PG_34:1-
d31 
775.6939, 776.7002, 777.7065, 778.7127 -ve 3.0 
IS_PA_34:1-
d31 
700.6509, 701.6571, 702.6634, 703.6697, 704.6760 -ve 3.4 
IS_Cer_16:0-
d31 
548.6851, 549.6914, 550.6977, 551.7039, 566.6951, 567.7014, 
568.7076, 569.7139, 590.6896, 591.6959, 606.6636, 607.6698 
+ve 3.9 
IS_PC_34:1-
d31 
790.7700, 791.7750, 812.7553, 813.7616, 828.7292, 829.7355 +ve 3.9 
IS_PE_34:1-
d31 
747.7181, 748.7254, 749.7327, 769.7021, 770.7084, 771.7146, 
785.6760, 786.6823, 787.6886 
+ve 4.0 
IS_TG_45:0-
d87 
850.2239, 851.2301, 852.2364, 853.2427, 867.2504, 868.2567, 
869.2630, 870.2693, 872.2059, 873.2121, 874.2184, 875.2247, 
888.1798, 889.1861, 890.1923, 891.1986 
+ve 5.8 
As shown in the table above (see Table 2), the internal standards have multiple ionisation 
products, these are the result of numerous ionisation mechanism (for example IS_TG_45:0-d87 
having different adducts: [M+H]+, [M+Na]+, [M+K]+ and [M+NH4]+, present) as well as an isotopic 
distribution (e.g., IS_TG_45:0-d87 having either the expected eighty-seven or fewer deuterium atoms 
present) all reasonably expected ions were included into the EIC for each internal standard (see 
Figure 4). 
 
Figure 4. This figure shows a spiked (5 µM in methanol) commercial human plasma extracted ion 
chromatogram (EIC) for the stable isotope-labelled internal standards (lipids and acyl-carnitines): 
butyryl-d7-L-carnitine (abbreviated to IS_Car_4:0-d7); area ~5.9e6 counts, N-
tetradecylphosphocholine-d42 (abbreviated to IS_LPC_14:0-d42); are ~2.1e8 counts, hexadecanoyl-L-
carnitine-d3 (abbreviated to IS_Car_16:0-d3); area ~5.8e8 counts, heptadecanoic-d33 acid (abbreviated 
to IS_FA_17:0-d33); area ~1.1e4 counts, 1,2-dimyristoyl-d54-sn-glycero-3-[phospho-L-serine] 
(abbreviated to IS_PS_28:0-d54); area ~2.2e7 counts, 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-
phosphoinositol (abbreviated to IS_PI_34:1-d31): area ~1.1e7 counts, N-palmitoyl-d31-D-erythro-
sphingosylphosphorylcholine (abbreviated to IS_SM_34:1-d31); 1.4e8 counts, 1-palmitoyl-d31-2-
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oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (abbreviated to IS_PG_34:1-d31); area ~6.1e7 counts, 1-
palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphate (abbreviated to IS_PA_34:1-d31); area ~1.3e7 counts, 
N-palmitoyl-d31-D-erythro-sphingosine (abbreviated to IS_Cer_16:0-d31); area ~2.2e8 counts, 1-
palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphocholine (abbreviated to IS_PC_34:1-d31); area ~2.5e8 
counts, 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphoethanolamine (abbreviated to IS_PE_34:1-
d31); area ~6.3e7 counts, glyceryl tri(pentadecanoate-d29) (abbreviated to IS_TG_45:0-d87); area 
~3.2e7 counts. 
The adduct composition of the total EIC produced from each of the ionisation mechanisms are 
shown in the figure below (see Figure 5). 
 
Figure 5. This figure shows the intensity of the extracted ion chromatogram for each stable isotope-
labelled internal standard along with the ionisation adduct composition: [M+H]+, [M+H-H2O]+, 
[M+NH4]+, [M+Na]+, [M+K]+ and [M-H]-. Butyryl-d7-L-carnitine (abbreviated to IS_Car_4:0-d7), N-
tetradecylphosphocholine-d42 (abbreviated to IS_LPC_14:0-d42), hexadecanoyl-L-carnitine-d3 
(abbreviated to IS_Car_16:0-d3), heptadecanoic-d33 acid (abbreviated to IS_FA_17:0-d33), 1,2-
dimyristoyl-d54-sn-glycero-3-[phospho-L-serine] (abbreviated to IS_PS_28:0-d54), 1-palmitoyl-d31-2-
oleoyl-sn-glycero-3-phosphoinositol (abbreviated to IS_PI_34:1-d31), N-palmitoyl-d31-D-erythro-
sphingosylphosphorylcholine (abbreviated to IS_SM_34:1-d31), 1-palmitoyl-d31-2-oleoyl-sn-glycero-
3-[phospho-rac-(1-glycerol)] (abbreviated to IS_PG_34:1-d31), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-
phosphate (abbreviated to IS_PA_34:1-d31), N-palmitoyl-d31-D-erythro-sphingosine (abbreviated to 
IS_Cer_16:0-d31), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphocholine (abbreviated to IS_PC_34:1-
d31), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphoethanolamine (abbreviated to IS_PE_34:1-d31), 
glyceryl tri(pentadecanoate-d29) (abbreviated to IS_TG_45:0-d87). 
The data processing also involved the integration of the individual lipid (and derivatives) 
species at their expected retention time (see Supplementary Table S2) allowing for a maximum of ±0.1 
min of retention time drift: any retention time drift greater than ±0.1 min resulted in the exclusion of 
the analyte leading to a ‘Not Found’ result (i.e., zero concentration). A list of the analyte classes along 
with the number of species detected within each class are shown in the table below (see Table 3). The 
expected adducts for each analyte class and the internal standard used for semi-quantitation are also 
shown. 
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Table 3. This table shows the lipid classes detected with this LC–MS lipidomics method. The number 
of species per lipid class and the measured adducts (protonated: [M+H]+, deprotonated: [M-H]-, 
protonated with water loss: [M+H-H2O]+, sodiated: [M+Na]+, potasiated: [M+K]+, ammoniated: 
[M+NH4]+) are also shown. The internal standard used for semi-quantification are also shown: 
butyryl-d7-L-carnitine (abbreviated to IS_Car_4:0-d7), N-tetradecylphosphocholine-d42 (abbreviated 
to IS_LPC_14:0-d42), hexadecanoyl-L-carnitine-d3 (abbreviated to IS_Car_16:0-d3), heptadecanoic-
d33 acid (abbreviated to IS_FA_17:0-d33), 1,2-dimyristoyl-d54-sn-glycero-3-[phospho-L-serine] 
(abbreviated to IS_PS_28:0-d54), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphoinositol (abbreviated 
to IS_PI_34:1-d31), N-palmitoyl-d31-D-erythro-sphingosylphosphorylcholine (abbreviated to 
IS_SM_34:1-d31), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (abbreviated to 
IS_PG_34:1-d31), 1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphate (abbreviated to IS_PA_34:1-d31), 
N-palmitoyl-d31-D-erythro-sphingosine (abbreviated to IS_Cer_16:0-d31), 1-palmitoyl-d31-2-oleoyl-
sn-glycero-3-phosphocholine (abbreviated to IS_PC_34:1-d31), 1 palmitoyl-d31-2-oleoyl-sn-glycero-
3-phosphoethanolamine (abbreviated to IS_PE_34:1-d31), glyceryl tri(pentadecanoate-d29) 
(abbreviated to IS_TG_45:0-d87). 
Analyte Class No. of Species Adducts Internal Standard 
Acyl-carnitines 48 [M+H]+ IS_Car_4:0-d7, IS_Car_16:0-d3 
Ceramides 85 [M+H]+, [M+H-H2O]+ IS_Cer_16:0-d31 
Cardiolipins 56 [M-H]- IS_TG_45:0-d87 
Diacylglycerols 6 [M+H-H2O]+, [M+Na]+, [M+K]+ IS_TG_45:0-d87 
Gangliosides (GM1) 24 [M-H]- IS_PG_34:1-d31 
Hexosylceramides 56 [M+H]+, [M+H-H2O]+ IS_Cer_16:0-d31 
Lyso-phosphatidylcholines 23 [M+H]+ IS_LPC_14:0-d42 
Lyso-phosphatidyethanolamines 19 [M+H]+ IS_LPC_14:0-d42 
Lyso-phosphatidylinositols 19 [M-H]- IS_PI_34:1-d31 
Lyso-phosphoserines 20 [M-H]- IS_PS_28:0-d54 
Lyso-cardiolipins 23 [M-H]- IS_TG_45:0-d87 
Monoacylglycerols 1 [M+H-H2O]+, [M+Na]+, [M+K]+ IS_TG_45:0-d87 
Phosphatidic acids 26 [M-H]- IS_PA_34:1-d31 
Phosphatidylcholines 43 [M+H]+ IS_PC_34:1-d31 
Phosphatidylethanolamines 19 [M+H]+ IS_PE_34:1-d31 
Phosphatidylglycerol 34 [M-H]- IS_PG_34:1-d31 
Phosphatidylinositols 21 [M-H]- IS_PI_34:1-d31 
Phosphatidylserines 36 [M-H]- IS_PS_28:0-d54 
Sulfatides 72 [M-H]- IS_PG_34:1-d31 
Sphingomyelins 54 [M+H]+, [M+Na]+, [M+K]+ IS_SM_34:1-d31 
Triacylglycerides 89 [M+H]+, [M+NH4]+, [M+Na]+, [M+K]+ IS_TG_45:0-d87 
The lipid quality control (QC) standards were analysed with each batch of samples, these QC 
standards were used to check the retention times for the analytes ensuring that isobaric analytes were 
separated and expected analyte retention times remained robust. 
Through the Thermo Xcalibur Quan Browser software, the responses of the analytes were 
normalised to the relevant internal standard response (producing area ratios) (see Supplementary 
Table S2), these area ratios corrected the intensity for any extraction and instrument variations. The 
area ratios were then blank corrected where intensities less than three times the blank samples were 
set to a ‘Not Found’ result (i.e., zero concentration). The accepted area ratios were then multiplied by 
the concentration of the internal standard to give the analyte concentrations. The results for fluid 
samples were expressed in molar concentrations (typically µM or nM). For tissue samples, the 
calculated concentrations of the analytes were then divided by the amount of tissue (in mg) used in 
the extraction protocol to give the final results in µM per mg of tissue extracted (µM/mg). 
4.5. Animal Intervention 
Sprague–Dawley rats (Harlan, IN, USA) were overfed using one of four experimental diets (n = 
6–9 per group) at 17% above matched growth via an intragastric cannula surgically inserted as 
previously described [26]. Animals had ad libitum access to water throughout the experiments. The 
four experimental diets were 70% fat (% energy) including different amounts of medium chain 
triacylglycerides oil (MCT), beef tallow and corn oil; the fat composition of each diet are shown in the 
table below (see Table 4). 
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Table 4. This table shows the dietary fat composition of each of the four experimental diets fed to 
Sprague–Dawley rats (n = 8–9 per group). MCT: medium chain triglyceride oil. 
Diet Corn Oil MCT Oil Beef Tallow 
1 50% 16.4% 3.6% 
2 35% 28.7% 6.3% 
3 20% 41.0% 9.0% 
4 5% 53.3% 11.7% 
Protein (19% whey protein), vitamin and mineral contents were the same in all diets. Diets were 
formulated to meet the caloric and nutritional recommendations established by the National 
Research Council (NRC), but were fed at a level that exceeded the recommended caloric intake by 
17% to increase weight gain and adiposity and produce steatohepatitis. 
Liver tissue was collected after 21 days. All experimental procedures were ethically approved 
by the Institutional Animal Care and Use Committee at the University of Arkansas for Medical 
Science. 
5. Conclusions 
This lipidomics protocol has been developed to quantify lipids across a broad range of 
hydrophobicities, from acyl-carnitines through to long chain glycerolipids. The extraction method 
produces a single liquid supernatant phase ideal for high-throughput workflows with an increased 
extraction capability over the frequently published liquid–liquid extraction previously published by 
Folch and colleagues [12]. 
Following the establishment and validation of this method, we applied it to a ruminant fat dose 
response dietary intervention in Sprague–Dawley rats, where we found 100 lipid species correlated 
strongly with the composition of ruminant fat within the diet. 
It has been previously suggested that dietary ruminant fat is beneficial/protective in type 2 
diabetes [32], the results presented in this manuscript suggest possible target mechanisms that need 
to be examined could include ceramide fatty acid compositions, cardiolipin remodeling, 
sphingomyelins and/or triacylglycerides concentration (particularly unsaturated odd chain species) 
and their associated fatty acid compositions, as well as the liver total lipid content. 
Supplementary Materials: The following are available online at www.mdpi.com/2218-1989/10/7/296/s1, Figure 
S1: This figure shows the comparison between the two lipid extraction techniques regarding their extraction 
efficiency on each lipid class detected in the rat liver samples (Folch liquid–liquid extraction with a compositions 
of chloroform: methanol: water, ~7:3:4, and Protein precipitation liquid extraction with a composition of 
chloroform: methanol: acetone, ~7:3:4). n = 34 rat liver samples per extraction method. The intensity of the lipids 
were measured by liquid chromatography with mass spectrometry. The significance of the difference between 
the two extraction protocols are shown by the p-value star system; where p ≤ 0.05 was considered statistically 
significant (* p < 0.05, ** p < 0.01, *** p < 0.001). Error bars represent ± standard deviation. Table S1: This table 
shows the comparison between the two lipid extraction techniques regarding their extraction efficiency on the 
total intensity of each lipid class detected in the rat liver samples by each sample extraction method (Folch-LLE: 
Folch liquid–liquid extraction with a compositions of chloroform: methanol: water, ~7:3:4, and PPLE: protein 
precipitation liquid extraction with a composition of chloroform: methanol: acetone, ~7:3:4). n = 34 rat liver 
samples per extraction method. The percentage increase the PPLE method is over the Folch-LLE method is 
shown (% diff.) along with the p-value resulting from a t-test (p < 0.05 designates statistical significance are in 
bold & shaded). The total number of lipid species detected and pass the quality control process are also shown. 
Table S2: This table shows the lipids quantified in this LC–MS method, along with the ionisation mode (either 
positive; +ve, or negative; -ve), the detected ion (m/z), the expected retention time (minutes) and the internal 
standard used for normalisation and quantification. Lipid are shown in their shorthand notations with the 
number of carbons and unsaturated bonds in the fatty acid moiety separated by a colon; acyl-carnitines (Carn), 
ceramides (Cer), cardiolipins (CL), diacylglycerols (DG), gangliosides (GM1), hexosylceramides (Hex-Cer), lyso-
phosphatidylcholines (LPC), lyso-phosphatidyethanolamines (LPE), lyso-phosphatidylinositols (LPI), lyso-
cardiolipins (Lyso_CL), phosphatidic acids (PA), phosphatidylcholines (PC), phosphatidylethanolamines (PE), 
phosphatidylglycerol (PG), phosphatidylinositols (PI), phosphatidylserines (PS), sulfatides (S), sphingomyelins 
(SM), triacylglycerides (TG). 
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